Diseases Associated With Exposure to Certain Herbicide Agents (Hairy Cell Leukemia and Other Chronic B Cell Leukemias, Parkinson's Disease and Ischemic Heart Disease), 14391-14401 [2010-6549]
Download as PDF
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
address, and dates of the meeting
remain as previously published.
FOR FURTHER INFORMATION CONTACT:
Rodger J. Boyd, Deputy Assistant
Secretary for Native American
Programs, Office of Public and Indian
Housing, Department of Housing and
Urban Development, 451 Seventh Street,
SW., Room 4126, Washington, DC
20410; telephone number 202–401–7914
(this is not a toll-free number). Hearing
or speech-impaired individuals may
access this number via TTY by calling
the toll-free Federal Information Relay
Service at 1–800–877–8339.
Correction
In the Federal Register of March 19,
2010, on page 13243, in the second
column, correct the ADDRESSES caption
to read:
ADDRESSES: The meeting will take place
at the Doubletree Paradise Valley Resort,
5401 North Scottsdale Road, Scottsdale,
Arizona 85250; telephone number 480–
947–5400 (this is not a toll-free
number).
Dated: March 19, 2010.
Aaron Santa Anna,
Assistant General Counsel for Legislation and
Regulation.
[FR Doc. 2010–6609 Filed 3–24–10; 8:45 am]
BILLING CODE 4210–67–P
DEPARTMENT OF VETERANS
AFFAIRS
38 CFR Part 3
RIN 2900–AN54
Diseases Associated With Exposure to
Certain Herbicide Agents (Hairy Cell
Leukemia and Other Chronic B Cell
Leukemias, Parkinson’s Disease and
Ischemic Heart Disease)
Department of Veterans Affairs.
Proposed rule.
AGENCY:
mstockstill on DSKH9S0YB1PROD with PROPOSALS
ACTION:
SUMMARY: The Department of Veterans
Affairs (VA) is proposing to amend its
adjudication regulations concerning
presumptive service connection for
certain diseases based upon the most
recent National Academy of Sciences
(NAS) Institute of Medicine committee
report, Veterans and Agent Orange:
Update 2008 (Update 2008). This
proposed amendment is necessary to
implement a decision of the Secretary of
Veterans Affairs that there is a positive
association between exposure to
herbicides and the subsequent
development of hairy cell leukemia and
other chronic B-cell leukemias,
Parkinson’s disease, and ischemic heart
disease. The intended effect of this
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
proposed amendment is to establish
presumptive service connection for
these diseases based on herbicide
exposure.
DATES: Comments must be received by
VA on or before April 26, 2010.
ADDRESSES: Written comments may be
submitted through https://
www.Regulations.gov; by mail or handdelivery to Director, Regulations
Management (02REG), Department of
Veterans Affairs, 810 Vermont Ave.,
NW., Room 1068, Washington, DC
20420; or by fax to (202) 273–9026.
(This is not a toll free number.)
Comments should indicate that they are
submitted in response to ‘‘RIN 2900–
AN54—Diseases Associated With
Exposure to Certain Herbicide Agents
(Hairy Cell Leukemia and other Chronic
B Cell Leukemias, Parkinson’s Disease
and Ischemic Heart Disease).’’ Copies of
comments received will be available for
public inspection in the Office of
Regulation Policy and Management,
Room 1063B, between the hours of
8 a.m. and 4:30 p.m., Monday through
Friday (except holidays). Please call
(202) 461–4902 for an appointment.
(This is not a toll free number.) In
addition, during the comment period,
comments may be viewed online
through the Federal Docket Management
System at https://www.Regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Gerald Johnson, Regulations Staff
(211D), Compensation and Pension
Service, Veterans Benefits
Administration, Department of Veterans
Affairs, 810 Vermont Avenue, NW.,
Washington, DC 20420, (202) 461–9727
(This is not a toll-free number.)
SUPPLEMENTARY INFORMATION: Section 3
of the Agent Orange Act of 1991, Public
Law 102–4, 105 Stat. 11, directed the
Secretary to seek to enter into an
agreement with NAS to review and
summarize the scientific evidence
concerning the association between
exposure to herbicides used in support
of military operations in the Republic of
Vietnam during the Vietnam era and
each disease suspected to be associated
with such exposure. Congress mandated
that NAS determine, to the extent
possible: (1) Whether there is a
statistical association between the
suspect diseases and herbicide
exposure, taking into account the
strength of the scientific evidence and
the appropriateness of the methods used
to detect the association; (2) the
increased risk of disease among
individuals exposed to herbicides
during service in the Republic of
Vietnam during the Vietnam era; and (3)
whether there is a plausible biological
mechanism or other evidence of a causal
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
14391
relationship between herbicide
exposure and the suspect disease.
Section 3 of Public Law 102–4 also
required that NAS submit reports on its
activities every 2 years (as measured
from the date of the first report) for a
10-year period. The Veterans Education
and Benefits Expansion Act of 2001
(Benefits Expansion Act), Public Law
107–103, § 201(d), extended through
October 1, 2014, the period for
submission of NAS reports. Section
1116(b) of title 38, United States Code,
as enacted by the Agent Orange Act of
1991, Public Law 102–4, provides that
whenever the Secretary determines,
based on sound medical and scientific
evidence, that a positive association
(i.e., the credible evidence for the
association is equal to or outweighs the
credible evidence against the
association) exists between exposure of
humans to an herbicide agent (i.e., a
chemical in an herbicide used in
support of the United States and allied
military operations in the Republic of
Vietnam during the Vietnam era) and a
disease, the Secretary will publish
regulations establishing presumptive
service connection for that disease.
Section 2 of the Agent Orange Act of
1991, Public Law 102–4, provided that
the congressional mandate that the
Secretary establish presumptions of
service connection under 38 U.S.C.
1116(b) would expire 10 years after the
first day of the fiscal year in which the
NAS transmitted its first report to VA.
The first NAS report was transmitted to
VA in July 1993, during the fiscal year
that began on October 1, 1992.
Accordingly, under the Agent Orange
Act of 1991, Public Law 102–4, the
mandate for VA to issue regulatory
presumptions as specified in section
1116(b) expired on September 30, 2002.
In December 2001, however, Congress
enacted the Benefits Expansion Act,
section 201(d) of which extended the
mandate under section 1116(b) through
September 30, 2015. Pursuant to the
Benefits Expansion Act, Public Law
107–103, VA must issue new
regulations between October 1, 2002,
and September 30, 2015, establishing
additional presumptions of service
connection for diseases that the
Secretary finds to be associated with
exposure to an herbicide agent.
The Secretary of Veterans Affairs has
determined that the available scientific
and medical evidence discussed in the
‘‘Veterans and Agent Orange Update
2008,’’ authored by the Committee to
Review the Health Effects in Vietnam
Veterans of Exposure to Herbicides,
Institute of Medicine (IOM) of the NAS,
and other information available to the
Secretary, are sufficient to establish that
E:\FR\FM\25MRP1.SGM
25MRP1
14392
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
mstockstill on DSKH9S0YB1PROD with PROPOSALS
a positive association exists between
exposure of humans to a herbicide agent
and the occurrence in humans of Hairy
Cell Leukemia (HCL) and other Chronic
B-Cell Leukemias, Parkinson’s disease
(PD) and Ischemic Heart Disease (IHD).
Consistent with that determination and
as required by 38 U.S.C. 1116(b) and the
Agent Orange Act of 1991, we propose
to amend VA’s adjudication regulations
(38 CFR part 3) by revising section
3.309(e) to add these diseases to the
diseases subject to presumptive service
connection on the basis of herbicide
exposure.
Hairy Cell Leukemia and Other Chronic
B-Cell Leukemias
In delivering the charge to the IOM
Committee, the Secretary specifically
asked the IOM Committee, whether the
occurrence of HCL should be regarded
as associated with exposure to the
chemical compounds in the herbicides
used by the military in Vietnam. HCL is
a chronic B-cell lymphoproliferative
disorder. Because it is so rare, the
Committee reported that HCL would
never be studied epidemiologically on
its own, and there are no studies of
animals that describe HCL in animals
exposed to the compounds of interest.
The IOM Committee stated that HCL has
been classified as a rare form of CLL and
that both derive from B-cell neoplasms.
Based on its biology, the Committee saw
no reason to exclude HCL or any other
chronic lymphoproliferative disease of
B-cell origin from the overarching
broader groupings for which positive
epidemiologic evidence is available.
Because HCL is related to chronic
lymphocytic leukemia (CLL) (a disease
that is already included on VA’s
regulatory list of diseases that qualify
for presumptive service connection
based upon herbicide exposure), the
Committee explicitly included HCL and
other chronic B-cell leukemias in its
discussions and conclusions regarding
CLL. The Committee explicitly recategorized HCL and other chronic
B-cell leukemias along with CLL in
Update 2008, which the Committee lists
as a category clarification since Update
2006. Based on its review of the
available scientific and medical
literature, the Committee concluded that
there is sufficient evidence of an
association between exposure to
herbicide agents and CLL, including
HCL and all other chronic B-cell
hematoproliferative leukemias.
The Secretary has determined that the
available scientific and medical
evidence presented in Update 2008 and
other information available to the
Secretary are sufficient to establish a
new presumption of service connection
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
for HCL and other chronic B-cell
leukemias in veterans who were
exposed to herbicides used in the
Republic of Vietnam. The Secretary
concludes that the credible evidence for
an association between exposure to an
herbicide agent and the occurrence of
HCL and other chronic B-cell leukemias
in humans outweighs the credible
evidence against such an association.
Accordingly, the Secretary has
determined that a presumption of
service connection for HCL and other
chronic B-cell leukemias is warranted
pursuant to 38 U.S.C. 1116(b). Because
these leukemias are related to CLL and
the evidence supporting an association
is the same for these leukemias, we
propose to refer to them as a group in
VA’s regulatory list in 38 CFR 3.309(e)
of diseases associated with herbicide
exposure. Specifically, we propose to
establish a presumption of service
connection for ‘‘All chronic B-cell
leukemias (including, but not limited to,
hairy-cell leukemia and chronic
lymphocytic leukemia).’’
Parkinson’s Disease
In Update 2008, the Committee placed
Parkinson’s disease (PD) in the category
‘‘limited or suggestive evidence of an
association.’’ This was a category change
from IOM’s prior report, Veterans and
Agent Orange: Update 2006 (Update
2006). For Update 2008, the Committee
selectively reevaluated all past
epidemiologic studies that specifically
assessed herbicide exposures and
reviewed in detail those studies
published since Update 2006. The older
studies, taken as a group, suggest that
there is a relationship between pesticide
exposure and risk of PD, but generally
did not contain sufficient exposure data
to show an association specifically to
the herbicides of interest. However,
several studies published since Update
2006 now suggest a specific relationship
between exposure to the herbicides of
interest and PD. Three of the four
studies published since Update 2006
showed a statistically significant odds
ratio for development of PD and
exposure to herbicides, most notably to
2, 4-D and 2, 4, 5-T and other
chlorophenoxy herbicides. Accordingly,
the recent studies are consistent with
the body of epidemiologic and
toxicologic data suggesting a
relationship between exposure to
pesticides and PD, but provide more
specific evidence of an association
between PD and the herbicides used in
the Republic of Vietnam. The
Committee noted that, to date, no
studies have been done on Vietnam
veterans to determine if an increased
relative risk of developing PD exists for
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
this cohort, and the Committee
recommended that such studies be
done. Based upon the available
scientific and medical evidence, the
Committee placed PD in the category of
‘‘limited or suggestive evidence of an
association.’’
The Secretary requested expert
opinion from the Parkinson’s and
Associated Diseases Research and
Education Clinical Center (PADRECC)
network, a network of VA medical
professionals designed to focus on care,
research, and education relating to PD.
These experts believe that there is an
increasing body of evidence indicating
exposure to herbicides increases the risk
of developing PD and developing it at
an earlier age. These experts also
identified a September 2008 report by
Tanner, et al., in Arch Neurol, 2008;
66(9):1106–1113, which found that the
risk of Parkinsonism was increased by
exposure to a variety of chemicals,
including dioxin-like chemicals of
interest in Update 2008. The Tanner
study was published after Update 2008
was completed but provides additional
support for an association between
herbicide exposure and PD.
The Secretary has determined that the
available scientific and medical
evidence presented in Update 2008 and
other information available to the
Secretary are sufficient to establish a
new presumption of service connection
for PD in veterans exposed to
herbicides, as the credible evidence for
an association between exposure to an
herbicide agent and the occurrence of
PD in humans outweighs the credible
evidence against such an association.
Ischemic Heart Disease
The previous Committee responsible
for Update 2006 was divided as to
whether the evidence related to IHD and
exposure to the compounds of interest
was sufficient to advance IHD from the
category of ‘‘inadequate or insufficient
evidence to determine whether an
association exists’’ to the category of
‘‘limited or suggestive evidence of an
association.’’ Due to the lack of
consensus, the 2006 Committee left IHD
in the ‘‘inadequate or insufficient
evidence’’ category.
For Update 2008, the Committee
revisited the entire body of evidence
relating herbicide exposure to heart
disease risk and placed more emphasis
on studies that had been rigorously
conducted. These studies focused
specifically on the chemicals of
concern, compared Vietnam veterans to
non-deployed Vietnam-era veterans, and
had individual and reliable measures of
exposure that permitted the evaluation
of dose-response, to promote the
E:\FR\FM\25MRP1.SGM
25MRP1
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
interpretation of epidemiologic data.
The Committee identified nine studies
(including two new studies) that were
deemed most informative. Of these nine
studies, five showed strong statistically
significant associations between
herbicide exposure and ischemic heart
disease. The studies considered by the
Committee also included data from
Agent Orange sprayers, occupationally
exposed populations, and
environmentally exposed populations
that were either prevalence surveys or
mortality follow-up studies. In
situations where several alternative
analyses were presented, the results
with the greatest specificity in the doseresponse relationship were given more
weight.
The Committee stated that evidence of
a dose-response relationship is
especially helpful in interpretation of
the epidemiological data, and the
Committee was impressed by the fact
that those studies with the best dose
information all showed evidence for risk
elevations in the highest exposure
categories. The Committee noted that
some of the study findings could be
limited by the effect of selection bias or
possible confounding factors. However,
the Committee noted that one of the
new studies showed an association that
persisted after statistical adjustments for
a large number of potential confounding
risk factors, which is not generally
available in studies of other dioxin
exposed populations. The Committee
also indicated that the major potential
confounders were likely inadequate to
explain away the high relative risks and
dose-response relationships seen in the
data for IHD. Further, the Committee
noted that toxicologic data supports the
biologic plausibility of an association
between exposure to the compounds of
interest and IHD.
After considering the relative
strengths and weaknesses of the
evidence, and emphasizing in particular
the numerous studies showing a strong
dose-response relationship and good
toxicology data regarding IHD, the
Committee concluded that there was
adequate information to advance IHD
from the ‘‘inadequate or insufficient
evidence’’ category to the ‘‘limited or
suggestive evidence’’ category.
The Secretary has determined that the
available scientific and medical
evidence presented in Update 2008 and
other information available to the
Secretary are sufficient to establish a
new presumption of service connection
for IHD in veterans exposed to
herbicides. After considering all of the
evidence, the Secretary has concluded
that the credible evidence for an
association between exposure to an
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
herbicide agent and the occurrence of
IHD in humans outweighs the credible
evidence against such an association.
Accordingly, the Secretary has
determined that a presumption of
service connection for IHD is warranted
pursuant to 38 U.S.C. 1116(b).
According to Harrison’s Principles of
Internal Medicine (Harrison’s Online,
Chapter 237, Ischemic Heart Disease,
2008), IHD is a condition in which there
is an inadequate supply of blood and
oxygen to a portion of the myocardium;
it typically occurs when there is an
imbalance between myocardial oxygen
supply and demand. Therefore, for
purposes of this regulation, the term
‘‘IHD’’ includes, but is not limited to,
acute, subacute, and old myocardial
infarction; atherosclerotic
cardiovascular disease including
coronary artery disease (including
coronary spasm) and coronary bypass
surgery; and stable, unstable and
Prinzmetal’s angina. Since the term
refers only to heart disease, it does not
include hypertension or peripheral
manifestations of arteriosclerosis such
as peripheral vascular disease or stroke.
Impact of the Nehmer Class Action
Litigation
Nehmer v. U.S. Department of
Veterans Affairs, Civ. Action No. 86–
6160 (N.D. Cal.) (TEH) (Nehmer) is a
long-standing class action (originated in
1986) on behalf of all veterans and
survivors of veterans eligible to claim
VA disability compensation benefits
based on exposure to herbicides in the
Republic of Vietnam during the Vietnam
era. In 1989, the U.S. District Court for
the Northern District of California
invalidated a 1985 VA regulation
governing claims based on herbicide
exposure. In 1991, the parties entered
into a stipulation to provide for readjudication of class members’ claims
and payment of retroactive benefits, if
warranted. Since that time, the district
court has issued a series of orders
interpreting the 1991 stipulation to
impose ongoing duties on VA.
Consistent with those orders, whenever
VA identifies a new disease that is
associated with herbicide exposure and
adds a new disease to its regulatory list,
it must identify and readjudicate any
previously-filed claims by the class
members involving that disease and, if
warranted under VA regulations
governing Nehmer awards, must pay
benefits retroactive to the date the prior
claim was received by VA to the veteran
or, if the veteran is deceased, to the
veteran’s surviving spouse, child, or
parents. In July 2007, the U.S. Court of
Appeals for the Ninth Circuit rejected
VA’s position that its duties under the
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
14393
Nehmer stipulation have ended and
held that VA’s duties extend through at
least 2015. Nehmer v. U.S. Dept. of
Veterans Affairs, 494 F.3d 846, 862–63
(9th Cir. 2007). Accordingly, the
requirements of the Nehmer court
orders for review of previously denied
claims and for retroactive payment will
apply to the proposed new
presumptions, to the extent consistent
with the court orders and 38 CFR 3.816,
the VA regulation implementing those
orders. The impact of these procedures
is discussed in the Regulatory Impact
Analysis below.
Paperwork Reduction Act
The collection of information under
the Paperwork Reduction Act (44 U.S.C.
3501–3521) that is contained in this
document is authorized under OMB
Control No. 2900–0001.
Executive Order 12866
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
when regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety, and other advantages;
distributive impacts; and equity). The
Executive Order classifies a regulatory
action as a ‘‘significant regulatory
action,’’ requiring review by the Office
of Management and Budget (OMB),
unless OMB waives such review, if it is
a regulatory action that is likely to result
in a rule that may: (1) Have an annual
effect on the economy of $100 million
or more or adversely affect in a material
way the economy, a sector of the
economy, productivity, competition,
jobs, the environment, public health or
safety, or State, local, or Tribal
governments or communities; (2) create
a serious inconsistency or otherwise
interfere with an action taken or
planned by another agency; (3)
materially alter the budgetary impact of
entitlements, grants, user fees, or loan
programs or the rights and obligations of
recipients thereof; or (4) raise novel
legal or policy issues arising out of legal
mandates, the President’s priorities, or
the principles set forth in the Executive
Order.
VA has examined the economic,
interagency, budgetary, legal, and policy
implications of this rulemaking and
determined that it is an economically
significant rule under this Executive
Order, because it will have an annual
effect on the economy of $100 million
or more. A Regulatory Impact Analysis
(RIA) must be prepared for major rules
with economically significant effects
($100 million or more in any 1 year).
E:\FR\FM\25MRP1.SGM
25MRP1
14394
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
Comment Period
Although under the rulemaking
guidelines in Executive Order 12866 VA
ordinarily provides a 60 day comment
period, the Secretary has determined
that there is good cause to limit the
public comment period on this
proposed rule to 30 days. This proposed
rule is necessary to implement section
1116(c) of title 38 as enacted by the
Agent Orange Act of 1991, Public Law
102–4, which sets forth time limits for
rulemaking when the Secretary
determines that a new presumption of
service connection for veterans exposed
to herbicides used in the Republic of
Vietnam is warranted. Those time limits
include the requirement for issuance of
final regulations ‘‘[n]ot later than 90
days after the date on which the
Secretary issues proposed regulations.’’
38 U.S.C. 1116(c)(2). The statute thus
requires VA to act expeditiously to issue
final rules, which will allow VA to
begin providing benefits to veterans and
their families based on this rule. A 30day notice and comment period is
necessary both to facilitate expeditious
issuance of final regulations and to
promote rapid action on affected
benefits claims.
Regulatory Impact Analysis
VA followed OMB Circular A–4 to the
extent feasible in this regulatory
analysis. The circular first calls for a
discussion of the Statement of Need for
the regulation. As discussed in the
preamble, the Agent Orange Act of 1991,
as codified at 38 U.S.C. 1116 requires
the Secretary of Veterans Affairs to
publish regulations establishing a
presumption of service connection for
those diseases determined to have a
positive association with herbicide
exposure in humans.
Statement of Need: On October 13th,
2009, the Secretary of Veterans Affairs,
Eric K. Shinseki, announced his intent
to establish presumptions of service
connection for PD, IHD, and hairy cell/
B cell leukemia for veterans who were
exposed to herbicides used in the
Republic of Vietnam during the Vietnam
era.
Summary of the Legal Basis: This
rulemaking is necessary because the
Agent Orange Act of 1991 requires the
Secretary to promulgate regulations
establishing a presumption of service
connection once he finds a positive
association between exposure to
herbicides used in the Republic of
Vietnam during the Vietnam era and the
Benefits Costs ($000s)
subsequent development of any
particular disease.
Alternatives: There are no feasible
alternatives to this rulemaking, since the
Agent Orange Act of 1991 requires the
Secretary to initiate rulemaking once the
Secretary finds a positive association
between a disease and herbicide
exposure in Vietnam during the
Vietnam era.
Risks: The rule implements statutorily
required provisions to expand veteran
benefits. No risk to the public exists.
Anticipated Costs and Benefits: We
estimate the total cost for this
rulemaking to be $13.6 billion during
the first year (FY2010), $25.3 billion for
5 years, and $42.2 billion over 10 years.
These amounts include benefits costs
and government operating expenses for
both Veterans Benefits Administration
(VBA) and Veterans Health
Administration (VHA). A detailed cost
analysis for each Administration is
provided below.
Veterans Benefits Administration (VBA)
Costs
We estimate VBA’s total cost to be
$13.4 billion during the first year
(FY2010), $24.3 billion for five years,
and $39.7 billion over ten years.
1st year (FY10)
5 year
10 year
Retroactive benefits costs* ....................................................................................................
Recurring costs from Retroactive Processing .......................................................................
Increased benefits costs for Veterans currently on the rolls .................................................
Accessions .............................................................................................................................
12,286,048
0
415,927
675,214
**12,286,048
4,388,773
2,188,784
4,645,609
**12,286,048
10,300,132
4,864,755
11,330,294
Administrative Costs
FTE costs ...............................................................................................................................
New office space (minor construction) ..................................................................................
IT equipment ..........................................................................................................................
***4,554
..........................
..........................
797,473
12,835
30,232
894,614
12,835
32,805
Totals ..............................................................................................................................
13,381,743
24,349,746
39,721,476
* Retroactive benefits costs are paid in the first year only.
** Inserted for cumulative totals.
*** FTE costs in FY 2010 represent a level of effort of current FTE that will be used to work claims received in FY2010. New hiring will begin in
2011.
Of the total VBA benefits costs
identified for FY 2010, $12.3 billion
accounts for retroactive benefit
payments. Ten-year total costs for
ischemic heart disease is $31.9 billion,
Parkinson’s disease accounts for $3.5
billion, and hairy cell and B cell
leukemia is the remaining $3.4 billion.
TOTAL OBLIGATIONS BY PRESUMPTIVE CONDITION
Retroactive
payments
mstockstill on DSKH9S0YB1PROD with PROPOSALS
($000’s)
1st year
5 year
10 year
Ischemic Heart disease ...........................................................................
Parkinson’s ..............................................................................................
Hairy Cell/B cell Leukemia ......................................................................
$9,877,787
692,204
1,716,057
$900,470
166,300
24,372
$9,307,716
1,189,143
726,306
$21,978,301
2,796,852
1,720,028
Subtotal .............................................................................................
12,286,048
1,091,142
11,223,165
26,495,181
Total ...........................................................................................
12,286,048
*13,377,190
*23,509,213
*38,781,229
* Includes Retroactive Payments.
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
PO 00000
Frm 00034
Fmt 4702
Sfmt 4702
E:\FR\FM\25MRP1.SGM
25MRP1
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
Methodology
The cost estimate for the three
presumptive conditions considers
retroactive benefit payments for
Veterans and survivors, increases for
Veterans currently on the compensation
rolls, and potential accessions for
Veterans and survivors. There are
numerous assumptions made for the
purposes of this cost estimate. At a
minimum, four of those could vary
considerably and the result could be
dramatic increases or decreases to the
mandatory benefit numbers provided.
The estimate assumes:
• A prevalence rate of 5.6% for IHD
based upon information extracted from
the CDC’s Web site. Even slight
variations to this number will result in
significant changes.
• An 80% application rate in most
instances. We have prior experiences
that have been as low as in the 70%
range and as high as in the 90% range.
• New enrollees will, on average, be
determined to have about a 60% degree
of disability for IHD. This would mirror
the degree of disability for the current
Vietnam Veteran population on VA’s
rolls. However, most of the individuals
have had the benefit of VHA health care.
We cannot be certain that the new
population of Vietnam Veterans coming
into the system will mirror that average.
• Only the benefit costs of the
presumptive conditions listed.
Secondary conditions, particularly to
IHD, may manifest themselves and
result in even higher degrees of
disability ultimately being granted.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
Retroactive Veteran and Survivor
Payments
Vietnam Veterans Previously Denied
In 2010, approximately, 86,069
Vietnam beneficiaries (as of August
2009 provided by PA&I) will be eligible
to receive retroactive payments for the
new presumptive conditions under the
provisions of 38 CFR 3.816 (Nehmer). Of
this total, 69,957 are living Vietnam
Veterans, of which 62,206 were denied
for IHD, 5,441 were denied for hairy cell
or B cell leukemia, and the remaining
2,310 for Parkinson’s disease. Of those
previously denied service connection
for the three new presumptive
conditions, 52,918, or nearly 76 percent,
are currently on the rolls for other
service-connected disabilities.
Compensation and Pension (C&P)
Service assumes the average degree of
disability for both Parkinson’s disease
and hairy cell/B cell leukemia will be
100 percent, and IHD will be 60 percent.
Based on the Combined Rating Table,
we assume Veterans currently not on
the rolls would access at the percentages
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
identified above. For those Veterans
currently on the rolls for other serviceconnected disabilities, we assume they
would receive a retroactive award based
on the higher combined disability
rating. For example, a Veteran who is on
the rolls and rated 10 percent disabled
who establishes presumptive service
connection for Parkinson’s disease will
result in a higher combined rating of
100 percent and receive a retroactive
award for the difference. For purposes
of this cost estimate, we assumed that
Veterans previously denied service
connection for one of the three new
conditions who are currently receiving
benefits were awarded benefits for
another disability concurrently.
Based on the Nehmer case review in
conjunction with the August 2006 Haas
Court of Appeals for Veterans Claims
(CAVC) decision, C&P Service identified
an average retroactive payment of 11.38
years for Veterans whose claims were
previously denied. Obligations for
retroactive payments for Veterans not
currently on the rolls were calculated by
applying the caseload to the benefit
payments by degree of disability,
multiplied by the average number of
years for Veterans’ claims. For those
who are on the rolls, based on a
distribution by degree of disability,
obligations were calculated by applying
the increased combined degree of
disability for those currently rated zero
to ninety percent. Of the total 52,918
currently on the rolls, 8,348 are
currently rated 100 percent disabled
and, therefore, would not likely receive
a retroactive award payment.
Of the total 86,069 Vietnam
beneficiaries, a total of 69,957 are living
Vietnam Veterans. Of this total, 52,918
are currently on the rolls for other
service-connected disabilities and
17,039 are off the compensation rolls
(52,918 + 17,039 = 69,957). Of the
52,918 Vietnam Veterans who are on the
rolls, 8,348 are currently rated 100
percent disabled and would not likely
receive a retroactive payment
(17,039¥8,348 = 8,691 + 52,918 =
61,609).
14395
VETERAN CASELOAD AND OBLIGATIONS
FOR RETROACTIVE BENEFITS—Continued
Presumptive
conditions
Total ...............
Caseload
Retroactive
payments
($000’s)
61,609
9,615,875
Vietnam Veteran Survivors Previously
Denied
Survivor caseload was determined
based on Veteran terminations. Based
on data obtained from PA&I, of the
86,069 previous denials, 16,112 of the
Vietnam Veterans are deceased. Of the
deceased population, 13,420 were
Veterans previously denied claims for
IHD, 2,165 were denied for hairy cell or
B cell leukemia, and 527 were denied
for Parkinson’s disease. We assumed
that 90 percent of the survivor caseload
will be new to the rolls and the
remaining ten percent are currently in
receipt of survivor benefits.
The 2001 National Survey of Veterans
found that approximately 75 percent of
Veterans are married. With the marriage
rate applied, we estimate there are
12,084 survivors in 2010. Based on the
Nehmer case review in conjunction with
the August 2006 Haas Court of Appeals
for Veterans Claims (CAVC) decision,
C&P Service identified an average
retroactive payment of 9.62 years for
Veterans’ survivors. Under Nehmer, in
addition to survivor dependency and
indemnity compensation (DIC) benefits,
survivors are also entitled to the
Veteran’s retroactive benefit payment to
the date of the Veteran’s death.
Obligations for survivors who were
denied claims were determined by
applying the survivor caseload for each
presumptive condition to the average
survivor compensation benefit payment
from the 2010 President’s Budget and
the average number of years for the
survivor’s claim (9.62 years). Veteran
benefit payments to which survivors are
entitled were calculated similarly with
the exception of applying the survivor
caseload for each presumptive condition
to the difference between the average
VETERAN CASELOAD AND OBLIGATIONS Veteran claim of 11.38 years and the
FOR RETROACTIVE BENEFITS
average survivor claim of 9.62 years.
The estimated remaining 4,028 deceased
Retroactive Veterans who were not married would
Presumptive
Caseload
payments
conditions
have their retroactive benefit payment
($000’s)
applied to their estate.
Ischemic Heart
Of the 86,069 Vietnam beneficiaries, a
Disease .............
54,926
$7,837,369
total of 16,112 are Vietnam Veterans
Parkinson’s Disease ..................
2,042
568,920 that are deceased. Of this total, an
estimated 12,084 were married and an
Hairy Cell/B Cell
Leukemia ...........
4,641
1,209,586 estimated 4,028 were not married
(12,084 + 4,028 = 16,112).
PO 00000
Frm 00035
Fmt 4702
Sfmt 4702
E:\FR\FM\25MRP1.SGM
25MRP1
14396
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
SURVIVOR CASELOAD AND OBLIGATIONS FOR RETROACTIVE BENEFITS
Presumptive
conditions
Caseload
Retroactive
payments
($000’s)
Recurring Veteran and Survivor
SURVIVOR CASELOAD AND OBLIGATIONS FOR RETROACTIVE BENE- Payments
FITS—Continued
Retroactive caseload obligations for
13,420
$2,040,418
527
Retroactive
payments
($000’s)
Hairy Cell/B Cell
Leukemia ...........
2,165
506,470
Total ..................
Ischemic Heart
Disease .............
Parkinson’s Disease ..................
Caseload
16,112
both Veterans and survivors become a
recurring cost and are reflected in outyear estimates. Mortality rates are
applied in the out years to determine
caseload.
2,670,173
Presumptive
conditions
123,284
RECURRING VETERAN AND SURVIVOR CASELOAD AND OBLIGATIONS FROM RETROACTIVE PROCESSING
Veteran
caseload
Survivor
caseload
Obligations
($000s)
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
N/A
61,365
61,243
61,121
61,000
60,879
60,758
60,637
60,517
60,397
N/A
10,672
10,570
10,458
10,336
10,201
10,052
9,891
9,716
9,526
N/A
1,079,310
1,084,209
1,102,800
1,122,454
1,142,251
1,162,167
1,182,189
1,202,298
1,222,453
Total ..........................................................................................................................................................
................
................
10,300,132
FY
mstockstill on DSKH9S0YB1PROD with PROPOSALS
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Vietnam Veterans (Reopened Claims)
We expect Veterans who are currently
on the compensation rolls and have any
of the three presumptive conditions to
file a claim and receive a higher
combined disability rating beginning in
2010. We anticipate that Veterans
receiving compensation for other
service-connected conditions will
continue to file claims over ten years.
Total costs are expected to be $415.9
million the first year and approximately
$4.9 billion over ten years.
According to the Defense Manpower
Data Center (DMDC), there are 2.6
million in-country Vietnam Veterans.
With mortality applied, an estimated 2.1
million will be alive in 2010. C&P
Service assumes that 34 percent of this
population are service connected for
other conditions and are already in
receipt of compensation benefits. In
2010, we anticipate that 725,547
Vietnam Veterans will be receiving
compensation benefits. This number is
further reduced by the number of
Veterans identified in the previous
estimate for retroactive claims (52,918).
C&P Service assumes an average age of
63 for all Vietnam Veterans. With
prevalence and mortality rates applied,
and an estimated 80 percent application
rate and 100 percent grant rate, we
calculate that 32,606 Veterans currently
on the rolls will have a presumptive
condition in 2010. Of this total, we
anticipate 27,909 cases will result in
increased obligations. Of the 27,909
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
Veterans, 25,859 are associated with
IHD, 1,693 are associated with
Parkinson’s disease, and the remaining
357 are associated with hairy cell/B cell
leukemia. In future years, the estimated
number of Veteran reopened claims
decreases to almost one thousand cases
and continue at a decreasing rate. The
cumulative effect of additional cases
with mortality rates applied is shown in
the chart below.
The Vietnam Era caseload distribution
by degree of disability provided by C&P
Service was used to further distribute
the total Vietnam Veterans who will
have a presumptive condition in 2010
by degree of disability for each of the
three new presumptive conditions. We
assume 100 percent for the average
degree of disability for both Parkinson’s
disease and hairy cell/B cell leukemia
and 60 percent for IHD. Based on the
Combined Rating Table, Veterans that
are on the rolls for other serviceconnected conditions (with the
exception of those that are currently
receiving compensation benefits for 100
percent disability), would receive a
higher combined disability rating if they
have any of the three new presumptive
conditions.
September average payments from the
2010 President’s Budget were used to
calculate obligations. These average
payments are higher than schedular
rates due to adjustments for dependents,
Special Monthly Compensation, and
Individual Unemployability. The
PO 00000
Frm 00036
Fmt 4702
Sfmt 4702
difference in average payments due to
higher ratings was calculated,
annualized, and applied to the on-rolls
caseload to determine increased
obligations. Because this particular
Veteran population is currently in
receipt of compensation benefits,
survivor caseload and obligations would
not be impacted.
REOPENED CASELOAD AND
OBLIGATIONS
Veteran
caseload
Obligations
($000s)
......................
......................
......................
......................
......................
......................
......................
......................
......................
......................
27,909
28,340
29,051
29,746
30,425
31,086
31,746
32,404
33,061
33,716
415,927
418,928
431,726
451,042
471,161
491,648
512,767
534,529
556,958
580,070
Total ..................
................
4,864,755
FY
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Vietnam Veteran and Survivor
Accessions
We anticipate accessions for both
Veterans and survivors beginning in
2010 and continuing over ten years.
Total costs are expected to be $675.2
million in the first year and total just
over $11.3 billion from the cumulative
effect of cases accessing the rolls each
year.
E:\FR\FM\25MRP1.SGM
25MRP1
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
To identify the number of Veteran
accessions in 2010, we applied
prevalence rates to the anticipated
living Vietnam Veteran population of
2,133,962, and reduced the population
by those identified in the previous
estimates for retroactive and reopened
claims. Based on an expected
application rate of 80 percent and a 100
percent grant rate, 28,934 accessions are
expected. Of the 28,934 Veteran
accessions, 25,505 are associated with
IHD, 3,074 are associated with
Parkinson’s disease, and the remaining
355 are associated with hairy cell/B cell
leukemia. In the out years, anticipated
Veteran accessions drop to
approximately 3,400 cases in 2011, and
continue at a decreasing rate. The
cumulative effect of additional cases
coupled with applying mortality rates is
shown in the chart below.
To calculate obligations, the caseload
was multiplied by the annualized
average payment. We assumed those
accessing the rolls due to IHD will be
rated 60 percent disabled and those
with either Parkinson’s disease or hairy
cell/B cell leukemia will be rated 100
percent disabled. Average payments
were based on the 2010 President’s
Budget with the Cost of Living
Adjustments factored into the out years.
The caseload for survivor
compensation is associated with the
number of service-connected Veterans’
deaths. There are two groups to consider
for survivor accessions: Those survivors
associated with Veterans who never
filed a claim and died prior to 2010; and
survivors associated with the mortality
rate applied to the Veteran accessions
noted above.
To calculate the survivor caseload
associated with Veterans who never
filed a claim and died prior to 2010,
general mortality rates were applied to
the estimated total Vietnam Veteran
population (2.6 million). We estimate
that almost 500,000 Vietnam Veterans
were deceased by 2010. Prevalence rates
for each condition were applied to the
14397
total Veteran deaths to estimate the
number of deaths due to each condition.
With the marriage rate and survivor
mortality applied, we anticipate 20,961
eligible spouses at the end of 2010. We
assume that half of this population will
apply in 2010 and the remaining in
2011. Obligations were calculated by
applying average survivor compensation
payments to the caseload each year.
The second group of survivors
associated with Veteran accessions was
calculated by applying mortality rates
for each of the presumptive conditions
to the estimated eligible Veteran
population (28,934). In 2010, 57 Veteran
deaths are anticipated as a result of one
of the new presumptive conditions.
With the marriage rate applied and
aging the spouse population (and
assuming spouses were the same age as
Veterans), we calculated 42 spouses at
the end of 2010. Average survivor
compensation payments were applied to
the spouse caseload to determine total
obligations.
VETERAN AND SURVIVOR ACCESSIONS CUMULATIVE CASELOAD AND TOTAL OBLIGATIONS
Veteran
caseload
Survivor
caseload
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
.................................................................................................................................................................
28,934
32,270
35,541
38,744
41,874
44,928
47,900
50,787
53,583
56,285
10,416
20,265
20,693
20,487
20,283
20,081
19,881
19,682
19,485
19,290
$675,214
882,974
955,525
1,028,467
1,103,429
1,179,725
1,257,259
1,335,922
1,415,601
1,496,178
Total ..........................................................................................................................................................
................
................
11,330,294
FY
mstockstill on DSKH9S0YB1PROD with PROPOSALS
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
Estimated Claims From Veterans Not
Eligible
Based on program history, we
anticipate that we will also receive
claims from Veterans who will not be
eligible for presumptive service
connection for the three new conditions.
These claims will be received from
two primary populations:
• Veterans with a presumptive
disease who did not serve in the
Republic of Vietnam.
• Claims from Vietnam Veterans with
hypertension who claim ‘‘heart disease.’’
We applied the prevalence rate of
IHD, Parkinson’s disease and hairy cell/
B cell leukemia to the estimated
population of Veterans who served in
Southeast Asia during the Vietnam Era
(45,304, 32, and 6 respectively), and
assumed that 10 percent of that
population will apply for presumptive
service connection.
Review of data obtained from PA&I
shows that 23 percent of Vietnam
Veterans who have been denied
entitlement to service connection for
hypertension also have nonserviceconnected heart disease. We applied the
prevalence rate of hypertension to the
living Vietnam Veteran population, and
then subtracted 23 percent who are
Total
obligations
assumed to also have IHD. We assumed
that 10 percent of the remaining
population would apply for
presumptive service connection to
arrive at an estimated caseload of
111,256.
We then assumed that 25 percent of
the ineligible population would apply
in 2010, 25 percent would apply in
2011, and the remaining population
would apply over the next 8 years. For
purposes of claims processing,
anticipated claims are as follows. The
chart below reflects workload, which is
not directly comparable to the preceding
caseload charts.
TOTAL CLAIMS
FY
Retroactive
claims
2010 .....................................................................................
2011 .....................................................................................
86,069
........................
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
PO 00000
Frm 00037
Fmt 4702
Reopened
claims
Sfmt 4702
32,606
1,069
Accessions
39,350
13,806
E:\FR\FM\25MRP1.SGM
25MRP1
Claims not
eligible
27,814
27,814
Total claims
185,839
42,689
14398
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
TOTAL CLAIMS—Continued
Retroactive
claims
FY
2012
2013
2014
2015
2016
2017
2018
2019
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
VBA Administrative Costs
Administrative costs, including minor
construction and information
technology support are estimated to be
$4.6 million during FY2010, $841
million for five years and $940 million
over ten years.
C&P Service, along with the Office of
Field Operations, estimated the FTE that
would be required to process the
anticipated claims resulting from the
new presumptive conditions using the
following assumptions:.
1. 185,839 additional claims in
addition to the projected 1,146,508
receipts during FY2010. This includes:
• 86,069 retroactive readjudications
under Nehmer.
• 89,354 new and reopened claims
from veterans.
• 10,416 new claims from survivors.
2. The average number of days to
complete all claims in FY2010 will be
165.
3. Priority will be given to those
Agent Orange claims that fall in the
Nehmer class action.
In FY2010, we will leverage the
existing C&P workforce to process as
many of these new claims as possible,
once the regulation is approved, but
especially the Nehmer cases. However,
to fully accommodate this additional
claims volume with as little negative
impact as possible on the processing of
other claims, we plan to add 1,772
claims processors to be brought on in
the FY2011 budget and timeframe. This
approximate level of effort will be
sustained through 2012 and into 2013 in
order to process these claims without
Reopened
claims
........................
........................
........................
........................
........................
........................
........................
........................
Accessions
1,051
1,032
1,011
989
989
989
989
989
significantly degrading the processing of
the non-presumptive workload.
• Net administrative costs for payroll,
training, additional office space,
supplies and equipment are estimated to
be $4.6 million in FY2010, $165 million
in FY2011, $798 million over five years,
and $895 million over 10 years.
Additional support costs for minor
construction are expected to be $12.8
million over the five and ten year
period. Information Technology
(computers and support) are assumed to
require $30.2 million over five years and
$32.8 million over ten years.
Veterans Health Administration (VHA)
Costs
We estimate VHA’s total cost to be
$236 million during the first year
(FY2010), $976 million for five years,
and $2.5 billion over ten years.
FY2010 and FY2011 Summary:
• FY2010 new enrollee patients are
expected to number 8,680.
• FY2011 additional new enrollees
are expected to number 1,018.
• FY2010 costs for C&P examinations
are expected to be $114M.
• FY2011 costs for C&P examinations
are expected to be $23M.
• FY2010 health care costs (inclusive
of travel) are expected to be $236M
(using cost per patient of 13,500).
• FY2011 health care costs (inclusive
of travel) are expected to be $165M
(using cost per patient of 14,100).
• Combined costs are as follows:
Æ FY2010: $236M.
Æ FY2011: $165M.
3,386
3,329
3,267
3,201
3,129
3,053
2,971
2,885
Claims not
eligible
Total claims
6,954
6,954
6,954
6,954
6,953
6,953
6,953
6,953
11,391
11,314
11,232
11,143
11,071
10,995
10,913
10,827
Assumptions
• 30% of Veterans newly determined
to be service-connected will enroll and
will use VA health care.
• Newly enrolled Veterans will be
Priority Group 1 Veterans.
• The cost per patient is arrived at
using the average cost per Priority
Group 1 patient aged between 45–64.
• Every VBA case will require a new
exam.
• It is assumed that 100% of newly
enrolled Veterans will request mileage
reimbursement. The average amount of
mileage reimbursement claims per
Veteran is $511 (this amount reflects to
the FY2009 actual average amount).
Distribution of Disability Claims
VBA has established estimates for
claims workload for Veterans. Figure 1
provides breakdown of disability
claims.
Overall, VBA anticipates 69,957
claims. Of these, 17,039 will be for
Veterans whose previous claims for
disability compensation were denied.
Additionally, VBA anticipates reopened
claim volume of 32,606 claims in
FY2010 with subsequent decreases to
1,069 per year in FY2011. VBA
anticipates 28,934 accessions in
FY2010. These are new disability
compensation awards—for Veterans
who did not previously have an award
for service connected disability
compensation. Additionally, in FY2010
VBA anticipates disability claim volume
associated with the presumptive SC
determination to be 159,311 and to
exceed 270,000 through FY2019.
mstockstill on DSKH9S0YB1PROD with PROPOSALS
FIGURE 1
Retroactive
claims
Retroactive
claims
representing
new SC disability award
69,957
........................
........................
........................
17,039
........................
........................
........................
FY
2010
2011
2012
2013
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
PO 00000
Frm 00038
Fmt 4702
Sfmt 4702
Reopened
claims
32,606
1,069
1,051
1,032
E:\FR\FM\25MRP1.SGM
25MRP1
Accessions
28,934
3,393
3,335
3,273
Total disability
claim volume
159,311
31,207
10,289
10,227
14399
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
FIGURE 1—Continued
FY
Retroactive
claims
Retroactive
claims
representing
new SC disability award
2014 .....................................................................................
........................
........................
1,011
3,207
10,161
Subtotals .......................................................................
........................
........................
36,769
42,142
221,195
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
.....................................................................................
........................
........................
........................
........................
........................
........................
........................
........................
........................
........................
989
989
989
989
989
3,137
3,062
2,983
2,898
2,809
10,091
10,016
9,937
9,852
9,763
Totals ............................................................................
69,957
........................
41,714
57,031
270,854
2015
2016
2017
2018
2019
New Enrollments and Changed
Enrollments
The disability compensation
workload, the resulting increases in
service-connected patients, and the
increased combined service connected
percents will both add new patients to
VA’s health care system and will change
the priority levels of Veterans currently
enrolled in VA’s health care system.
For purposes of estimation, it is
assumed that 30% of Veterans
‘‘Accessions’’ will enroll in the system
each year. For FY2010, this means that
8,680 of the 28,934 Veteran
‘‘Accessions’’. Figure 2 provides the
estimate of new enrollments per year for
the ten year period. In all, it is estimated
that 17,109 new Veterans will enroll in
VA’s health care system.
FIGURE 2
FY
2010
2011
2012
2013
2014
New enrollees
per year
..........
..........
..........
..........
..........
8,680
1,018
1,001
982
962
Subtotals
12,643
2015 ..........
941
Reopened
claims
FIGURE 2—Continued
New enrollees
per year
New enrollees
cumulative
..........
..........
..........
..........
919
895
869
843
Totals ....
17,109
17,109
2016
2017
2018
2019
It is assumed that Veterans enrolling
will be Priority Group 1 Veterans and
that they will use VA health care
services.
For purposes of estimation, it is
assumed that 40% of the Veterans
whose claims are reopened will have
been enrolled in VA’s health care
system and that their Priority Group
will move from a copay required status
to a copay exempt status. Additionally,
it is assumed that their third party
New enrollees collections will be lost. It is assumed
cumulative
that 10% of the accessions will result in
8,680 changes to Veterans who are currently
9,698 enrolled. These Veterans would be
10,699 enrolled in a copay required status and
11,681 would move to copay exempt status. In
12,643
FY2010 it is estimated that 43,919
........................ Veterans would have their enrollment
status changed, and FY 2011 it is
13,584 estimated that an additional 767
Total disability
claim volume
Veterans would have their enrollment
status changed. Figure 3 provides these
estimated changes in enrollment status
per year and cumulatively.
14,502
15,397
16,267
17,109
FY
Accessions
FIGURE 3
Upgraded
enrollees per
year
FY
2010
2011
2012
2013
2014
Upgraded
enrollees
cumulative
..........
..........
..........
..........
..........
43,919
767
754
740
725
43,919
44,686
45,439
46,180
46,905
Subtotals
46,905
46,905
..........
..........
..........
..........
..........
709
702
694
685
677
47,614
48,316
49,010
49,695
50,372
Totals ....
50,372
50,372
2015
2016
2017
2018
2019
Disability Exams Associated Costs
It is assumed that each VBA case will
result in disability examinations for the
Veteran. In all, it is estimated that
270,854 disability examinations will
need to be performed. An escalation
factor of 4% is applied to cost of
disability examinations.
FIGURE 4
Total disability
claim volume
mstockstill on DSKH9S0YB1PROD with PROPOSALS
FY
2010
2011
2012
2013
2014
Cost per disability
exam *
Annual cost per
disability exams
...........................................................................................................................
...........................................................................................................................
...........................................................................................................................
...........................................................................................................................
...........................................................................................................................
159,311
31,207
10,289
10,227
10,161
$719
748
778
809
841
$114,544,609
23,335,346
8,001,451
8,271,365
8,546,705
Subtotals .............................................................................................................
221,195
..............................
162,699,475
10,091
10,016
9,937
9,852
9,763
875
910
946
984
1,023
8,827,339
9,112,200
9,401,942
9,694,379
9,991,075
2015
2016
2017
2018
2019
...........................................................................................................................
...........................................................................................................................
...........................................................................................................................
...........................................................................................................................
...........................................................................................................................
VerDate Nov<24>2008
17:55 Mar 24, 2010
Jkt 220001
PO 00000
Frm 00039
Fmt 4702
Sfmt 4702
E:\FR\FM\25MRP1.SGM
25MRP1
14400
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
FIGURE 4—Continued
Total disability
claim volume
FY
Totals ..................................................................................................................
270,854
Cost per disability
exam *
Annual cost per
disability exams
..............................
209,726,410
* Source: Allocation Resource Center.
examinations. The cost per patient is
arrived at using the average cost per
Priority Group 1 patient aged between
45–64. It is assumed that 100% of newly
enrolled Veterans will request mileage
reimbursement. The average amount of
Health Care and Total Costs
Figure 5 provides extended health
care costs per year and includes costs
for C&P disability examinations and
travel associated with C&P
mileage reimbursement claims per
Veteran is $511 (this amount reflects to
the FY2009 actual average amount).
Total costs over the 10-year period are
estimated to be in excess of $2.4B.
FIGURE 5
Annual cost per
disability exams
FY
2010
2011
2012
2013
2014
Cost per BT
mileage claim
Beneficiary travel
costs
(41.5 cents/mile)
Cost per
patient
Health care costs
per patient
Extended annual
costs
.................................
.................................
.................................
.................................
.................................
$114,544,609
23,335,346
8,001,451
8,271,365
8,546,705
$511
511
511
511
511
$4,435,582
4,955,729
5,466,985
5,968,736
6,460,369
$13,500
14,100
14,700
15,100
15,700
$117,182,700
136,743,210
157,269,420
176,375,550
198,488,820
$236,162,891
165,034,285
170,737,855
190,615,650
213,495,893
Subtotals ...................
162,699,475
........................
27,287,400
........................
786,059,700
976,046,575
.................................
.................................
.................................
.................................
.................................
8,827,339
9,112,200
9,401,942
9,694,379
9,991,075
511
511
511
511
511
6,941,271
7,410,675
7,867,969
8,312,233
8,742,852
16,300
17,100
17,900
18,800
19,800
221,414,310
247,989,330
275,609,880
305,812,080
338,764,140
237,182,919
264,512,205
292,879,791
323,818,692
357,498,068
Totals ........................
209,726,410
........................
66,562,400
........................
2,175,649,440
2,451,938,251
2015
2016
2017
2018
2019
Summary
Combined estimated increases in
health care costs and lost revenues are
presented in Figure 6.
FIGURE 6
2010
2011
2012
2013
2014
Regulatory Flexibility Act
Extended annual
costs
FY
................................
................................
................................
................................
................................
$236,162,891
165,034,285
170,737,855
190,615,650
213,495,893
Subtotals .....................
976,046,575
................................
................................
................................
................................
................................
237,182,919
264,512,205
292,879,791
323,818,692
357,498,068
Totals ..........................
mstockstill on DSKH9S0YB1PROD with PROPOSALS
2015
2016
2017
2018
2019
2,451,938,251
Unfunded Mandates
The Unfunded Mandates Reform Act
of 1995 requires, at 2 U.S.C. 1532, that
agencies prepare an assessment of
anticipated costs and benefits before
issuing any rule that may result in an
expenditure by State, local, and Tribal
governments, in the aggregate, or by the
VerDate Nov<24>2008
18:05 Mar 24, 2010
private sector, of $100 million or more
(adjusted annually for inflation) in any
given year. This rulemaking would have
no such effect on State, local, and Tribal
governments, or on the private sector.
Jkt 220001
The Secretary certifies that the
adoption of this proposed rule would
not have a significant economic impact
on a substantial number of small entities
as they are defined in the Regulatory
Flexibility Act, 5 U.S.C. 601–612. This
rule would not directly affect any small
entities; only individuals could be
directly affected. Therefore, under 5
U.S.C. 605(b), this rule is exempt from
the initial and final regulatory flexibility
analysis requirements of sections 603
and 604.
Congressional Review Act
Under the Congressional Review Act,
a major rule may not take effect until at
least 60 days after submission to
Congress of a report regarding the rule.
A major rule is one that would have an
annual effect on the economy of $100
million or more or have certain other
impacts. We have determined this
rulemaking to be a major rule under the
Congressional Review Act.
PO 00000
Frm 00040
Fmt 4702
Sfmt 4702
Catalog of Federal Domestic Assistance
Numbers and Titles
The Catalog of Federal Domestic
Assistance program numbers and titles
for this proposed rule are 64.109,
Veterans Compensation for ServiceConnected Disability, and 64.110,
Veterans Dependency and Indemnity
Compensation for Service-Connected
Death.
List of Subjects in 38 CFR Part 3
Administrative practice and
procedure, Claims, Disability benefits,
Health care, veterans, Vietnam.
Approved: December 23, 2009.
John R. Gingrich,
Chief of Staff, Department of Veterans Affairs.
For the reasons set out in the
preamble, VA is proposing to amend 38
CFR part 3 as follows:
PART 3—ADJUDICATION
Subpart A—Pension, Compensation,
and Dependency and Indemnity
Compensation
1. The authority citation for part 3,
subpart A continues to read as follows:
Authority: 38 U.S.C. 501(a), unless
otherwise noted.
E:\FR\FM\25MRP1.SGM
25MRP1
Federal Register / Vol. 75, No. 57 / Thursday, March 25, 2010 / Proposed Rules
§ 3.309
[Amended]
2. In § 3.309(e) the listing of diseases
is amended as follows:
a. By removing ‘‘Chronic lymphocytic
leukemia’’ and adding, in its place, ‘‘All
chronic B-cell leukemias (including, but
not limited to, hairy-cell leukemia and
chronic lymphocytic leukemia)’’.
b. By adding ‘‘Parkinson’s disease’’
immediately preceding ‘‘Acute and
subacute peripheral neuropathy’’.
c. By adding ‘‘Ischemic heart disease
(including, but not limited to, acute,
subacute, and old myocardial infarction;
atherosclerotic cardiovascular disease
including coronary artery disease
(including coronary spasm) and
coronary bypass surgery; and stable,
unstable and Prinzmetal’s angina)’’
immediately following ‘‘Hodgkin’s
disease’’.
[FR Doc. 2010–6549 Filed 3–24–10; 8:45 am]
BILLING CODE P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 52
[EPA–R05–OAR–2007–1043; FRL–9129–6]
Approval and Promulgation of Air
Quality Implementation Plans;
Michigan; PSD Regulations
mstockstill on DSKH9S0YB1PROD with PROPOSALS
AGENCY: Environmental Protection
Agency (EPA).
ACTION: Proposed rule.
SUMMARY: EPA proposes to convert a
conditional approval of revisions to the
Michigan State Implementation Plan
(SIP) to a full approval under the
Federal Clean Air Act (CAA). The
revisions consist of requirements of the
prevention of significant deterioration
(PSD) construction permit program in
Michigan. As required by the
conditional approval, Michigan has
submitted a SIP revision pertaining to
the ‘‘potential to emit’’ and ‘‘emission
unit’’ definitions and EPA has found the
revisions acceptable.
DATES: Comments must be received on
or before April 26, 2010.
ADDRESSES: Submit your comments,
identified by Docket ID No. EPA–R05–
OAR–2007–1043, by one of the
following methods:
1. www.regulations.gov: Follow the
on-line instructions for submitting
comments.
2. E-mail: blakley.pamela@epa.gov.
3. Fax: (312) 692–2450.
4. Mail: Pamela Blakley, Chief, Air
Permits Section, Air Programs Branch
(AR–18J), U.S. Environmental
Protection Agency, 77 West Jackson
Boulevard, Chicago, Illinois 60604.
VerDate Nov<24>2008
16:39 Mar 24, 2010
Jkt 220001
5. Hand Delivery: Pamela Blakley,
Chief, Air Permits Section, Air Programs
Branch (AR–18J), U.S. Environmental
Protection Agency, 77 West Jackson
Boulevard, Chicago, Illinois 60604.
Such deliveries are only accepted
during the Regional Office normal hours
of operation, and special arrangements
should be made for deliveries of boxed
information. The Regional Office official
hours of business are Monday through
Friday, 8:30 a.m. to 4:30 p.m., excluding
Federal holidays.
Please see the direct final rule which
is located in the Rules section of this
Federal Register for detailed
instructions on how to submit
comments.
FOR FURTHER INFORMATION CONTACT:
Laura Cossa, Environmental Engineer,
Air Permits Section, Air Programs
Branch (AR–18J), U.S. Environmental
Protection Agency, Region 5, 77 West
Jackson Boulevard, Chicago, Illinois
60604, (312) 886–0661,
cossa.laura@epa.gov.
In the
Final Rules section of this Federal
Register, EPA is approving the State’s
SIP submittal as a direct final rule
without prior proposal because the
Agency views this as a noncontroversial
submittal and anticipates no adverse
comments. A detailed rationale for the
approval is set forth in the direct final
rule. If no adverse comments are
received in response to this rule, no
further activity is contemplated. If EPA
receives adverse comments, the direct
final rule will be withdrawn and all
public comments received will be
addressed in a subsequent final rule
based on this proposed rule. EPA will
not institute a second comment period.
Any parties interested in commenting
on this action should do so at this time.
Please note that if EPA receives adverse
comment on an amendment, paragraph,
or section of this rule and if that
provision may be severed from the
remainder of the rule, EPA may adopt
as final those provisions of the rule that
are not the subject of an adverse
comment. For additional information,
see the direct final rule which is located
in the Rules section of this Federal
Register.
SUPPLEMENTARY INFORMATION:
Dated: March 11, 2010.
Walter W. Kovalick Jr.,
Acting Regional Administrator, Region 5.
[FR Doc. 2010–6475 Filed 3–24–10; 8:45 am]
BILLING CODE 6560–50–P
PO 00000
Frm 00041
Fmt 4702
Sfmt 4702
14401
FEDERAL COMMUNICATIONS
COMMISSION
47 CFR Parts 0 and 1
[GC Docket No. 10–44; FCC 10–32]
Amendment of Certain of the
Commission’s Rules of Practice and
Procedure and Rules of Commission
Organization
AGENCY: Federal Communications
Commission.
ACTION: Proposed rule.
SUMMARY: This document seeks
comment on proposed revisions to the
Commission’s procedural rules and
organizational rules. The proposals are
intended to increase efficiency and
modernize our procedures, enhance the
openness and transparency of
Commission proceedings, and clarify
certain procedural rules. We seek
comment on the proposed rule
language, as well as the other proposals
contained in this document.
DATES: Comments must be submitted by
May 10, 2010 and reply comments must
be submitted by June 8, 2010. Written
comments on the Paperwork Reduction
Act proposed information collection
requirements must be submitted by the
public, Office of Management and
Budget (OMB), and other interested
parties on or before May 24, 2010.
ADDRESSES: You may submit comments,
identified by GC Docket No. 10–44, by
any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Federal Communications
Commission’s Web Site: https://
fjallfoss.fcc.gov/ecfs2/. Follow the
instructions for submitting comments.
• People with Disabilities: Contact the
FCC to request reasonable
accommodations (accessible format
documents, sign language interpreters,
CART, etc.) by e-mail: FCC504@fcc.gov
or phone: 202–418–0530 or TTY: 202–
418–0432.
For detailed instructions for submitting
comments and additional information
on the rulemaking process, see the
SUPPLEMENTARY INFORMATION section of
this document.
FOR FURTHER INFORMATION CONTACT:
Richard Welch, Office of General
Counsel, 202–418–1740. For additional
information concerning the Paperwork
Reduction Act information collection
requirements contained in this
document, send an e-mail to
PRA@fcc.gov or contact Leslie Smith,
OMD, 202–418–0217.
E:\FR\FM\25MRP1.SGM
25MRP1
Agencies
[Federal Register Volume 75, Number 57 (Thursday, March 25, 2010)]
[Proposed Rules]
[Pages 14391-14401]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6549]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF VETERANS AFFAIRS
38 CFR Part 3
RIN 2900-AN54
Diseases Associated With Exposure to Certain Herbicide Agents
(Hairy Cell Leukemia and Other Chronic B Cell Leukemias, Parkinson's
Disease and Ischemic Heart Disease)
AGENCY: Department of Veterans Affairs.
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: The Department of Veterans Affairs (VA) is proposing to amend
its adjudication regulations concerning presumptive service connection
for certain diseases based upon the most recent National Academy of
Sciences (NAS) Institute of Medicine committee report, Veterans and
Agent Orange: Update 2008 (Update 2008). This proposed amendment is
necessary to implement a decision of the Secretary of Veterans Affairs
that there is a positive association between exposure to herbicides and
the subsequent development of hairy cell leukemia and other chronic B-
cell leukemias, Parkinson's disease, and ischemic heart disease. The
intended effect of this proposed amendment is to establish presumptive
service connection for these diseases based on herbicide exposure.
DATES: Comments must be received by VA on or before April 26, 2010.
ADDRESSES: Written comments may be submitted through https://www.Regulations.gov; by mail or hand-delivery to Director, Regulations
Management (02REG), Department of Veterans Affairs, 810 Vermont Ave.,
NW., Room 1068, Washington, DC 20420; or by fax to (202) 273-9026.
(This is not a toll free number.) Comments should indicate that they
are submitted in response to ``RIN 2900-
AN54[m x dash]Diseases Associated With Exposure to Certain
Herbicide Agents (Hairy Cell Leukemia and other Chronic B Cell
Leukemias, Parkinson's Disease and Ischemic Heart Disease).'' Copies of
comments received will be available for public inspection in the Office
of Regulation Policy and Management, Room 1063B, between the hours of 8
a.m. and 4:30 p.m., Monday through Friday (except holidays). Please
call (202) 461-4902 for an appointment. (This is not a toll free
number.) In addition, during the comment period, comments may be viewed
online through the Federal Docket Management System at https://www.Regulations.gov.
FOR FURTHER INFORMATION CONTACT: Gerald Johnson, Regulations Staff
(211D), Compensation and Pension Service, Veterans Benefits
Administration, Department of Veterans Affairs, 810 Vermont Avenue,
NW., Washington, DC 20420, (202) 461-9727 (This is not a toll-free
number.)
SUPPLEMENTARY INFORMATION: Section 3 of the Agent Orange Act of 1991,
Public Law 102-4, 105 Stat. 11, directed the Secretary to seek to enter
into an agreement with NAS to review and summarize the scientific
evidence concerning the association between exposure to herbicides used
in support of military operations in the Republic of Vietnam during the
Vietnam era and each disease suspected to be associated with such
exposure. Congress mandated that NAS determine, to the extent possible:
(1) Whether there is a statistical association between the suspect
diseases and herbicide exposure, taking into account the strength of
the scientific evidence and the appropriateness of the methods used to
detect the association; (2) the increased risk of disease among
individuals exposed to herbicides during service in the Republic of
Vietnam during the Vietnam era; and (3) whether there is a plausible
biological mechanism or other evidence of a causal relationship between
herbicide exposure and the suspect disease. Section 3 of Public Law
102-4 also required that NAS submit reports on its activities every 2
years (as measured from the date of the first report) for a 10-year
period. The Veterans Education and Benefits Expansion Act of 2001
(Benefits Expansion Act), Public Law 107-103, Sec. 201(d), extended
through October 1, 2014, the period for submission of NAS reports.
Section 1116(b) of title 38, United States Code, as enacted by the
Agent Orange Act of 1991, Public Law 102-4, provides that whenever the
Secretary determines, based on sound medical and scientific evidence,
that a positive association (i.e., the credible evidence for the
association is equal to or outweighs the credible evidence against the
association) exists between exposure of humans to an herbicide agent
(i.e., a chemical in an herbicide used in support of the United States
and allied military operations in the Republic of Vietnam during the
Vietnam era) and a disease, the Secretary will publish regulations
establishing presumptive service connection for that disease.
Section 2 of the Agent Orange Act of 1991, Public Law 102-4,
provided that the congressional mandate that the Secretary establish
presumptions of service connection under 38 U.S.C. 1116(b) would expire
10 years after the first day of the fiscal year in which the NAS
transmitted its first report to VA. The first NAS report was
transmitted to VA in July 1993, during the fiscal year that began on
October 1, 1992. Accordingly, under the Agent Orange Act of 1991,
Public Law 102-4, the mandate for VA to issue regulatory presumptions
as specified in section 1116(b) expired on September 30, 2002. In
December 2001, however, Congress enacted the Benefits Expansion Act,
section 201(d) of which extended the mandate under section 1116(b)
through September 30, 2015. Pursuant to the Benefits Expansion Act,
Public Law 107-103, VA must issue new regulations between October 1,
2002, and September 30, 2015, establishing additional presumptions of
service connection for diseases that the Secretary finds to be
associated with exposure to an herbicide agent.
The Secretary of Veterans Affairs has determined that the available
scientific and medical evidence discussed in the ``Veterans and Agent
Orange Update 2008,'' authored by the Committee to Review the Health
Effects in Vietnam Veterans of Exposure to Herbicides, Institute of
Medicine (IOM) of the NAS, and other information available to the
Secretary, are sufficient to establish that
[[Page 14392]]
a positive association exists between exposure of humans to a herbicide
agent and the occurrence in humans of Hairy Cell Leukemia (HCL) and
other Chronic B-Cell Leukemias, Parkinson's disease (PD) and Ischemic
Heart Disease (IHD). Consistent with that determination and as required
by 38 U.S.C. 1116(b) and the Agent Orange Act of 1991, we propose to
amend VA's adjudication regulations (38 CFR part 3) by revising section
3.309(e) to add these diseases to the diseases subject to presumptive
service connection on the basis of herbicide exposure.
Hairy Cell Leukemia and Other Chronic B-Cell Leukemias
In delivering the charge to the IOM Committee, the Secretary
specifically asked the IOM Committee, whether the occurrence of HCL
should be regarded as associated with exposure to the chemical
compounds in the herbicides used by the military in Vietnam. HCL is a
chronic B-cell lymphoproliferative disorder. Because it is so rare, the
Committee reported that HCL would never be studied epidemiologically on
its own, and there are no studies of animals that describe HCL in
animals exposed to the compounds of interest. The IOM Committee stated
that HCL has been classified as a rare form of CLL and that both derive
from B-cell neoplasms. Based on its biology, the Committee saw no
reason to exclude HCL or any other chronic lymphoproliferative disease
of B-cell origin from the overarching broader groupings for which
positive epidemiologic evidence is available. Because HCL is related to
chronic lymphocytic leukemia (CLL) (a disease that is already included
on VA's regulatory list of diseases that qualify for presumptive
service connection based upon herbicide exposure), the Committee
explicitly included HCL and other chronic B-cell leukemias in its
discussions and conclusions regarding CLL. The Committee explicitly re-
categorized HCL and other chronic B-cell leukemias along with CLL in
Update 2008, which the Committee lists as a category clarification
since Update 2006. Based on its review of the available scientific and
medical literature, the Committee concluded that there is sufficient
evidence of an association between exposure to herbicide agents and
CLL, including HCL and all other chronic B-cell hematoproliferative
leukemias.
The Secretary has determined that the available scientific and
medical evidence presented in Update 2008 and other information
available to the Secretary are sufficient to establish a new
presumption of service connection for HCL and other chronic B-cell
leukemias in veterans who were exposed to herbicides used in the
Republic of Vietnam. The Secretary concludes that the credible evidence
for an association between exposure to an herbicide agent and the
occurrence of HCL and other chronic B-cell leukemias in humans
outweighs the credible evidence against such an association.
Accordingly, the Secretary has determined that a presumption of service
connection for HCL and other chronic B-cell leukemias is warranted
pursuant to 38 U.S.C. 1116(b). Because these leukemias are related to
CLL and the evidence supporting an association is the same for these
leukemias, we propose to refer to them as a group in VA's regulatory
list in 38 CFR 3.309(e) of diseases associated with herbicide exposure.
Specifically, we propose to establish a presumption of service
connection for ``All chronic B-cell leukemias (including, but not
limited to, hairy-cell leukemia and chronic lymphocytic leukemia).''
Parkinson's Disease
In Update 2008, the Committee placed Parkinson's disease (PD) in
the category ``limited or suggestive evidence of an association.'' This
was a category change from IOM's prior report, Veterans and Agent
Orange: Update 2006 (Update 2006). For Update 2008, the Committee
selectively reevaluated all past epidemiologic studies that
specifically assessed herbicide exposures and reviewed in detail those
studies published since Update 2006. The older studies, taken as a
group, suggest that there is a relationship between pesticide exposure
and risk of PD, but generally did not contain sufficient exposure data
to show an association specifically to the herbicides of interest.
However, several studies published since Update 2006 now suggest a
specific relationship between exposure to the herbicides of interest
and PD. Three of the four studies published since Update 2006 showed a
statistically significant odds ratio for development of PD and exposure
to herbicides, most notably to 2, 4-D and 2, 4, 5-T and other
chlorophenoxy herbicides. Accordingly, the recent studies are
consistent with the body of epidemiologic and toxicologic data
suggesting a relationship between exposure to pesticides and PD, but
provide more specific evidence of an association between PD and the
herbicides used in the Republic of Vietnam. The Committee noted that,
to date, no studies have been done on Vietnam veterans to determine if
an increased relative risk of developing PD exists for this cohort, and
the Committee recommended that such studies be done. Based upon the
available scientific and medical evidence, the Committee placed PD in
the category of ``limited or suggestive evidence of an association.''
The Secretary requested expert opinion from the Parkinson's and
Associated Diseases Research and Education Clinical Center (PADRECC)
network, a network of VA medical professionals designed to focus on
care, research, and education relating to PD. These experts believe
that there is an increasing body of evidence indicating exposure to
herbicides increases the risk of developing PD and developing it at an
earlier age. These experts also identified a September 2008 report by
Tanner, et al., in Arch Neurol, 2008; 66(9):1106-1113, which found that
the risk of Parkinsonism was increased by exposure to a variety of
chemicals, including dioxin-like chemicals of interest in Update 2008.
The Tanner study was published after Update 2008 was completed but
provides additional support for an association between herbicide
exposure and PD.
The Secretary has determined that the available scientific and
medical evidence presented in Update 2008 and other information
available to the Secretary are sufficient to establish a new
presumption of service connection for PD in veterans exposed to
herbicides, as the credible evidence for an association between
exposure to an herbicide agent and the occurrence of PD in humans
outweighs the credible evidence against such an association.
Ischemic Heart Disease
The previous Committee responsible for Update 2006 was divided as
to whether the evidence related to IHD and exposure to the compounds of
interest was sufficient to advance IHD from the category of
``inadequate or insufficient evidence to determine whether an
association exists'' to the category of ``limited or suggestive
evidence of an association.'' Due to the lack of consensus, the 2006
Committee left IHD in the ``inadequate or insufficient evidence''
category.
For Update 2008, the Committee revisited the entire body of
evidence relating herbicide exposure to heart disease risk and placed
more emphasis on studies that had been rigorously conducted. These
studies focused specifically on the chemicals of concern, compared
Vietnam veterans to non-deployed Vietnam-era veterans, and had
individual and reliable measures of exposure that permitted the
evaluation of dose-response, to promote the
[[Page 14393]]
interpretation of epidemiologic data. The Committee identified nine
studies (including two new studies) that were deemed most informative.
Of these nine studies, five showed strong statistically significant
associations between herbicide exposure and ischemic heart disease. The
studies considered by the Committee also included data from Agent
Orange sprayers, occupationally exposed populations, and
environmentally exposed populations that were either prevalence surveys
or mortality follow-up studies. In situations where several alternative
analyses were presented, the results with the greatest specificity in
the dose-response relationship were given more weight.
The Committee stated that evidence of a dose-response relationship
is especially helpful in interpretation of the epidemiological data,
and the Committee was impressed by the fact that those studies with the
best dose information all showed evidence for risk elevations in the
highest exposure categories. The Committee noted that some of the study
findings could be limited by the effect of selection bias or possible
confounding factors. However, the Committee noted that one of the new
studies showed an association that persisted after statistical
adjustments for a large number of potential confounding risk factors,
which is not generally available in studies of other dioxin exposed
populations. The Committee also indicated that the major potential
confounders were likely inadequate to explain away the high relative
risks and dose-response relationships seen in the data for IHD.
Further, the Committee noted that toxicologic data supports the
biologic plausibility of an association between exposure to the
compounds of interest and IHD.
After considering the relative strengths and weaknesses of the
evidence, and emphasizing in particular the numerous studies showing a
strong dose-response relationship and good toxicology data regarding
IHD, the Committee concluded that there was adequate information to
advance IHD from the ``inadequate or insufficient evidence'' category
to the ``limited or suggestive evidence'' category.
The Secretary has determined that the available scientific and
medical evidence presented in Update 2008 and other information
available to the Secretary are sufficient to establish a new
presumption of service connection for IHD in veterans exposed to
herbicides. After considering all of the evidence, the Secretary has
concluded that the credible evidence for an association between
exposure to an herbicide agent and the occurrence of IHD in humans
outweighs the credible evidence against such an association.
Accordingly, the Secretary has determined that a presumption of service
connection for IHD is warranted pursuant to 38 U.S.C. 1116(b).
According to Harrison's Principles of Internal Medicine (Harrison's
Online, Chapter 237, Ischemic Heart Disease, 2008), IHD is a condition
in which there is an inadequate supply of blood and oxygen to a portion
of the myocardium; it typically occurs when there is an imbalance
between myocardial oxygen supply and demand. Therefore, for purposes of
this regulation, the term ``IHD'' includes, but is not limited to,
acute, subacute, and old myocardial infarction; atherosclerotic
cardiovascular disease including coronary artery disease (including
coronary spasm) and coronary bypass surgery; and stable, unstable and
Prinzmetal's angina. Since the term refers only to heart disease, it
does not include hypertension or peripheral manifestations of
arteriosclerosis such as peripheral vascular disease or stroke.
Impact of the Nehmer Class Action Litigation
Nehmer v. U.S. Department of Veterans Affairs, Civ. Action No. 86-
6160 (N.D. Cal.) (TEH) (Nehmer) is a long-standing class action
(originated in 1986) on behalf of all veterans and survivors of
veterans eligible to claim VA disability compensation benefits based on
exposure to herbicides in the Republic of Vietnam during the Vietnam
era. In 1989, the U.S. District Court for the Northern District of
California invalidated a 1985 VA regulation governing claims based on
herbicide exposure. In 1991, the parties entered into a stipulation to
provide for re-adjudication of class members' claims and payment of
retroactive benefits, if warranted. Since that time, the district court
has issued a series of orders interpreting the 1991 stipulation to
impose ongoing duties on VA. Consistent with those orders, whenever VA
identifies a new disease that is associated with herbicide exposure and
adds a new disease to its regulatory list, it must identify and
readjudicate any previously-filed claims by the class members involving
that disease and, if warranted under VA regulations governing Nehmer
awards, must pay benefits retroactive to the date the prior claim was
received by VA to the veteran or, if the veteran is deceased, to the
veteran's surviving spouse, child, or parents. In July 2007, the U.S.
Court of Appeals for the Ninth Circuit rejected VA's position that its
duties under the Nehmer stipulation have ended and held that VA's
duties extend through at least 2015. Nehmer v. U.S. Dept. of Veterans
Affairs, 494 F.3d 846, 862-63 (9th Cir. 2007). Accordingly, the
requirements of the Nehmer court orders for review of previously denied
claims and for retroactive payment will apply to the proposed new
presumptions, to the extent consistent with the court orders and 38 CFR
3.816, the VA regulation implementing those orders. The impact of these
procedures is discussed in the Regulatory Impact Analysis below.
Paperwork Reduction Act
The collection of information under the Paperwork Reduction Act (44
U.S.C. 3501-3521) that is contained in this document is authorized
under OMB Control No. 2900-0001.
Executive Order 12866
Executive Order 12866 directs agencies to assess all costs and
benefits of available regulatory alternatives and, when regulation is
necessary, to select regulatory approaches that maximize net benefits
(including potential economic, environmental, public health and safety,
and other advantages; distributive impacts; and equity). The Executive
Order classifies a regulatory action as a ``significant regulatory
action,'' requiring review by the Office of Management and Budget
(OMB), unless OMB waives such review, if it is a regulatory action that
is likely to result in a rule that may: (1) Have an annual effect on
the economy of $100 million or more or adversely affect in a material
way the economy, a sector of the economy, productivity, competition,
jobs, the environment, public health or safety, or State, local, or
Tribal governments or communities; (2) create a serious inconsistency
or otherwise interfere with an action taken or planned by another
agency; (3) materially alter the budgetary impact of entitlements,
grants, user fees, or loan programs or the rights and obligations of
recipients thereof; or (4) raise novel legal or policy issues arising
out of legal mandates, the President's priorities, or the principles
set forth in the Executive Order.
VA has examined the economic, interagency, budgetary, legal, and
policy implications of this rulemaking and determined that it is an
economically significant rule under this Executive Order, because it
will have an annual effect on the economy of $100 million or more. A
Regulatory Impact Analysis (RIA) must be prepared for major rules with
economically significant effects ($100 million or more in any 1 year).
[[Page 14394]]
Comment Period
Although under the rulemaking guidelines in Executive Order 12866
VA ordinarily provides a 60 day comment period, the Secretary has
determined that there is good cause to limit the public comment period
on this proposed rule to 30 days. This proposed rule is necessary to
implement section 1116(c) of title 38 as enacted by the Agent Orange
Act of 1991, Public Law 102-4, which sets forth time limits for
rulemaking when the Secretary determines that a new presumption of
service connection for veterans exposed to herbicides used in the
Republic of Vietnam is warranted. Those time limits include the
requirement for issuance of final regulations ``[n]ot later than 90
days after the date on which the Secretary issues proposed
regulations.'' 38 U.S.C. 1116(c)(2). The statute thus requires VA to
act expeditiously to issue final rules, which will allow VA to begin
providing benefits to veterans and their families based on this rule. A
30-day notice and comment period is necessary both to facilitate
expeditious issuance of final regulations and to promote rapid action
on affected benefits claims.
Regulatory Impact Analysis
VA followed OMB Circular A-4 to the extent feasible in this
regulatory analysis. The circular first calls for a discussion of the
Statement of Need for the regulation. As discussed in the preamble, the
Agent Orange Act of 1991, as codified at 38 U.S.C. 1116 requires the
Secretary of Veterans Affairs to publish regulations establishing a
presumption of service connection for those diseases determined to have
a positive association with herbicide exposure in humans.
Statement of Need: On October 13th, 2009, the Secretary of Veterans
Affairs, Eric K. Shinseki, announced his intent to establish
presumptions of service connection for PD, IHD, and hairy cell/B cell
leukemia for veterans who were exposed to herbicides used in the
Republic of Vietnam during the Vietnam era.
Summary of the Legal Basis: This rulemaking is necessary because
the Agent Orange Act of 1991 requires the Secretary to promulgate
regulations establishing a presumption of service connection once he
finds a positive association between exposure to herbicides used in the
Republic of Vietnam during the Vietnam era and the subsequent
development of any particular disease.
Alternatives: There are no feasible alternatives to this
rulemaking, since the Agent Orange Act of 1991 requires the Secretary
to initiate rulemaking once the Secretary finds a positive association
between a disease and herbicide exposure in Vietnam during the Vietnam
era.
Risks: The rule implements statutorily required provisions to
expand veteran benefits. No risk to the public exists.
Anticipated Costs and Benefits: We estimate the total cost for this
rulemaking to be $13.6 billion during the first year (FY2010), $25.3
billion for 5 years, and $42.2 billion over 10 years. These amounts
include benefits costs and government operating expenses for both
Veterans Benefits Administration (VBA) and Veterans Health
Administration (VHA). A detailed cost analysis for each Administration
is provided below.
Veterans Benefits Administration (VBA) Costs
We estimate VBA's total cost to be $13.4 billion during the first
year (FY2010), $24.3 billion for five years, and $39.7 billion over ten
years.
----------------------------------------------------------------------------------------------------------------
Benefits Costs ($000s) 1st year (FY10) 5 year 10 year
----------------------------------------------------------------------------------------------------------------
Retroactive benefits costs*.................................. 12,286,048 **12,286,048 **12,286,048
Recurring costs from Retroactive Processing.................. 0 4,388,773 10,300,132
Increased benefits costs for Veterans currently on the rolls. 415,927 2,188,784 4,864,755
Accessions................................................... 675,214 4,645,609 11,330,294
Administrative Costs
FTE costs.................................................... ***4,554 797,473 894,614
New office space (minor construction)........................ ............... 12,835 12,835
IT equipment................................................. ............... 30,232 32,805
--------------------------------------------------
Totals................................................... 13,381,743 24,349,746 39,721,476
----------------------------------------------------------------------------------------------------------------
* Retroactive benefits costs are paid in the first year only.
** Inserted for cumulative totals.
*** FTE costs in FY 2010 represent a level of effort of current FTE that will be used to work claims received in
FY2010. New hiring will begin in 2011.
Of the total VBA benefits costs identified for FY 2010, $12.3
billion accounts for retroactive benefit payments. Ten-year total costs
for ischemic heart disease is $31.9 billion, Parkinson's disease
accounts for $3.5 billion, and hairy cell and B cell leukemia is the
remaining $3.4 billion.
Total Obligations by Presumptive Condition
----------------------------------------------------------------------------------------------------------------
Retroactive
($000's) payments 1st year 5 year 10 year
----------------------------------------------------------------------------------------------------------------
Ischemic Heart disease...................... $9,877,787 $900,470 $9,307,716 $21,978,301
Parkinson's................................. 692,204 166,300 1,189,143 2,796,852
Hairy Cell/B cell Leukemia.................. 1,716,057 24,372 726,306 1,720,028
-------------------------------------------------------------------
Subtotal................................ 12,286,048 1,091,142 11,223,165 26,495,181
-------------------------------------------------------------------
Total............................... 12,286,048 *13,377,190 *23,509,213 *38,781,229
----------------------------------------------------------------------------------------------------------------
* Includes Retroactive Payments.
[[Page 14395]]
Methodology
The cost estimate for the three presumptive conditions considers
retroactive benefit payments for Veterans and survivors, increases for
Veterans currently on the compensation rolls, and potential accessions
for Veterans and survivors. There are numerous assumptions made for the
purposes of this cost estimate. At a minimum, four of those could vary
considerably and the result could be dramatic increases or decreases to
the mandatory benefit numbers provided.
The estimate assumes:
A prevalence rate of 5.6% for IHD based upon information
extracted from the CDC's Web site. Even slight variations to this
number will result in significant changes.
An 80% application rate in most instances. We have prior
experiences that have been as low as in the 70% range and as high as in
the 90% range.
New enrollees will, on average, be determined to have
about a 60% degree of disability for IHD. This would mirror the degree
of disability for the current Vietnam Veteran population on VA's rolls.
However, most of the individuals have had the benefit of VHA health
care. We cannot be certain that the new population of Vietnam Veterans
coming into the system will mirror that average.
Only the benefit costs of the presumptive conditions
listed. Secondary conditions, particularly to IHD, may manifest
themselves and result in even higher degrees of disability ultimately
being granted.
Retroactive Veteran and Survivor Payments
Vietnam Veterans Previously Denied
In 2010, approximately, 86,069 Vietnam beneficiaries (as of August
2009 provided by PA&I) will be eligible to receive retroactive payments
for the new presumptive conditions under the provisions of 38 CFR 3.816
(Nehmer). Of this total, 69,957 are living Vietnam Veterans, of which
62,206 were denied for IHD, 5,441 were denied for hairy cell or B cell
leukemia, and the remaining 2,310 for Parkinson's disease. Of those
previously denied service connection for the three new presumptive
conditions, 52,918, or nearly 76 percent, are currently on the rolls
for other service-connected disabilities.
Compensation and Pension (C&P) Service assumes the average degree
of disability for both Parkinson's disease and hairy cell/B cell
leukemia will be 100 percent, and IHD will be 60 percent. Based on the
Combined Rating Table, we assume Veterans currently not on the rolls
would access at the percentages identified above. For those Veterans
currently on the rolls for other service-connected disabilities, we
assume they would receive a retroactive award based on the higher
combined disability rating. For example, a Veteran who is on the rolls
and rated 10 percent disabled who establishes presumptive service
connection for Parkinson's disease will result in a higher combined
rating of 100 percent and receive a retroactive award for the
difference. For purposes of this cost estimate, we assumed that
Veterans previously denied service connection for one of the three new
conditions who are currently receiving benefits were awarded benefits
for another disability concurrently.
Based on the Nehmer case review in conjunction with the August 2006
Haas Court of Appeals for Veterans Claims (CAVC) decision, C&P Service
identified an average retroactive payment of 11.38 years for Veterans
whose claims were previously denied. Obligations for retroactive
payments for Veterans not currently on the rolls were calculated by
applying the caseload to the benefit payments by degree of disability,
multiplied by the average number of years for Veterans' claims. For
those who are on the rolls, based on a distribution by degree of
disability, obligations were calculated by applying the increased
combined degree of disability for those currently rated zero to ninety
percent. Of the total 52,918 currently on the rolls, 8,348 are
currently rated 100 percent disabled and, therefore, would not likely
receive a retroactive award payment.
Of the total 86,069 Vietnam beneficiaries, a total of 69,957 are
living Vietnam Veterans. Of this total, 52,918 are currently on the
rolls for other service-connected disabilities and 17,039 are off the
compensation rolls (52,918 + 17,039 = 69,957). Of the 52,918 Vietnam
Veterans who are on the rolls, 8,348 are currently rated 100 percent
disabled and would not likely receive a retroactive payment (17,039-
8,348 = 8,691 + 52,918 = 61,609).
Veteran Caseload and Obligations for Retroactive Benefits
------------------------------------------------------------------------
Retroactive
Presumptive conditions Caseload payments
($000's)
------------------------------------------------------------------------
Ischemic Heart Disease.......................... 54,926 $7,837,369
Parkinson's Disease............................. 2,042 568,920
Hairy Cell/B Cell Leukemia...................... 4,641 1,209,586
-----------------------
Total....................................... 61,609 9,615,875
------------------------------------------------------------------------
Vietnam Veteran Survivors Previously Denied
Survivor caseload was determined based on Veteran terminations.
Based on data obtained from PA&I, of the 86,069 previous denials,
16,112 of the Vietnam Veterans are deceased. Of the deceased
population, 13,420 were Veterans previously denied claims for IHD,
2,165 were denied for hairy cell or B cell leukemia, and 527 were
denied for Parkinson's disease. We assumed that 90 percent of the
survivor caseload will be new to the rolls and the remaining ten
percent are currently in receipt of survivor benefits.
The 2001 National Survey of Veterans found that approximately 75
percent of Veterans are married. With the marriage rate applied, we
estimate there are 12,084 survivors in 2010. Based on the Nehmer case
review in conjunction with the August 2006 Haas Court of Appeals for
Veterans Claims (CAVC) decision, C&P Service identified an average
retroactive payment of 9.62 years for Veterans' survivors. Under
Nehmer, in addition to survivor dependency and indemnity compensation
(DIC) benefits, survivors are also entitled to the Veteran's
retroactive benefit payment to the date of the Veteran's death.
Obligations for survivors who were denied claims were determined by
applying the survivor caseload for each presumptive condition to the
average survivor compensation benefit payment from the 2010 President's
Budget and the average number of years for the survivor's claim (9.62
years). Veteran benefit payments to which survivors are entitled were
calculated similarly with the exception of applying the survivor
caseload for each presumptive condition to the difference between the
average Veteran claim of 11.38 years and the average survivor claim of
9.62 years. The estimated remaining 4,028 deceased Veterans who were
not married would have their retroactive benefit payment applied to
their estate.
Of the 86,069 Vietnam beneficiaries, a total of 16,112 are Vietnam
Veterans that are deceased. Of this total, an estimated 12,084 were
married and an estimated 4,028 were not married (12,084 + 4,028 =
16,112).
[[Page 14396]]
Survivor Caseload and Obligations for Retroactive Benefits
------------------------------------------------------------------------
Retroactive
Presumptive conditions Caseload payments
($000's)
------------------------------------------------------------------------
Ischemic Heart Disease.......................... 13,420 $2,040,418
Parkinson's Disease............................. 527 123,284
Hairy Cell/B Cell Leukemia...................... 2,165 506,470
-----------------------
Total......................................... 16,112 2,670,173
------------------------------------------------------------------------
Recurring Veteran and Survivor Payments
Retroactive caseload obligations for both Veterans and survivors
become a recurring cost and are reflected in out-year estimates.
Mortality rates are applied in the out years to determine caseload.
Recurring Veteran and Survivor Caseload and Obligations From Retroactive
Processing
------------------------------------------------------------------------
Veteran Survivor Obligations
FY caseload caseload ($000s)
------------------------------------------------------------------------
2010................................. N/A N/A N/A
2011................................. 61,365 10,672 1,079,310
2012................................. 61,243 10,570 1,084,209
2013................................. 61,121 10,458 1,102,800
2014................................. 61,000 10,336 1,122,454
2015................................. 60,879 10,201 1,142,251
2016................................. 60,758 10,052 1,162,167
2017................................. 60,637 9,891 1,182,189
2018................................. 60,517 9,716 1,202,298
2019................................. 60,397 9,526 1,222,453
----------------------------------
Total............................ ......... ......... 10,300,132
------------------------------------------------------------------------
Vietnam Veterans (Reopened Claims)
We expect Veterans who are currently on the compensation rolls and
have any of the three presumptive conditions to file a claim and
receive a higher combined disability rating beginning in 2010. We
anticipate that Veterans receiving compensation for other service-
connected conditions will continue to file claims over ten years. Total
costs are expected to be $415.9 million the first year and
approximately $4.9 billion over ten years.
According to the Defense Manpower Data Center (DMDC), there are 2.6
million in-country Vietnam Veterans. With mortality applied, an
estimated 2.1 million will be alive in 2010. C&P Service assumes that
34 percent of this population are service connected for other
conditions and are already in receipt of compensation benefits. In
2010, we anticipate that 725,547 Vietnam Veterans will be receiving
compensation benefits. This number is further reduced by the number of
Veterans identified in the previous estimate for retroactive claims
(52,918). C&P Service assumes an average age of 63 for all Vietnam
Veterans. With prevalence and mortality rates applied, and an estimated
80 percent application rate and 100 percent grant rate, we calculate
that 32,606 Veterans currently on the rolls will have a presumptive
condition in 2010. Of this total, we anticipate 27,909 cases will
result in increased obligations. Of the 27,909 Veterans, 25,859 are
associated with IHD, 1,693 are associated with Parkinson's disease, and
the remaining 357 are associated with hairy cell/B cell leukemia. In
future years, the estimated number of Veteran reopened claims decreases
to almost one thousand cases and continue at a decreasing rate. The
cumulative effect of additional cases with mortality rates applied is
shown in the chart below.
The Vietnam Era caseload distribution by degree of disability
provided by C&P Service was used to further distribute the total
Vietnam Veterans who will have a presumptive condition in 2010 by
degree of disability for each of the three new presumptive conditions.
We assume 100 percent for the average degree of disability for both
Parkinson's disease and hairy cell/B cell leukemia and 60 percent for
IHD. Based on the Combined Rating Table, Veterans that are on the rolls
for other service-connected conditions (with the exception of those
that are currently receiving compensation benefits for 100 percent
disability), would receive a higher combined disability rating if they
have any of the three new presumptive conditions.
September average payments from the 2010 President's Budget were
used to calculate obligations. These average payments are higher than
schedular rates due to adjustments for dependents, Special Monthly
Compensation, and Individual Unemployability. The difference in average
payments due to higher ratings was calculated, annualized, and applied
to the on-rolls caseload to determine increased obligations. Because
this particular Veteran population is currently in receipt of
compensation benefits, survivor caseload and obligations would not be
impacted.
Reopened Caseload and Obligations
------------------------------------------------------------------------
Veteran Obligations
FY caseload ($000s)
------------------------------------------------------------------------
2010............................................ 27,909 415,927
2011............................................ 28,340 418,928
2012............................................ 29,051 431,726
2013............................................ 29,746 451,042
2014............................................ 30,425 471,161
2015............................................ 31,086 491,648
2016............................................ 31,746 512,767
2017............................................ 32,404 534,529
2018............................................ 33,061 556,958
2019............................................ 33,716 580,070
-----------------------
Total......................................... ......... 4,864,755
------------------------------------------------------------------------
Vietnam Veteran and Survivor Accessions
We anticipate accessions for both Veterans and survivors beginning
in 2010 and continuing over ten years. Total costs are expected to be
$675.2 million in the first year and total just over $11.3 billion from
the cumulative effect of cases accessing the rolls each year.
[[Page 14397]]
To identify the number of Veteran accessions in 2010, we applied
prevalence rates to the anticipated living Vietnam Veteran population
of 2,133,962, and reduced the population by those identified in the
previous estimates for retroactive and reopened claims. Based on an
expected application rate of 80 percent and a 100 percent grant rate,
28,934 accessions are expected. Of the 28,934 Veteran accessions,
25,505 are associated with IHD, 3,074 are associated with Parkinson's
disease, and the remaining 355 are associated with hairy cell/B cell
leukemia. In the out years, anticipated Veteran accessions drop to
approximately 3,400 cases in 2011, and continue at a decreasing rate.
The cumulative effect of additional cases coupled with applying
mortality rates is shown in the chart below.
To calculate obligations, the caseload was multiplied by the
annualized average payment. We assumed those accessing the rolls due to
IHD will be rated 60 percent disabled and those with either Parkinson's
disease or hairy cell/B cell leukemia will be rated 100 percent
disabled. Average payments were based on the 2010 President's Budget
with the Cost of Living Adjustments factored into the out years.
The caseload for survivor compensation is associated with the
number of service-connected Veterans' deaths. There are two groups to
consider for survivor accessions: Those survivors associated with
Veterans who never filed a claim and died prior to 2010; and survivors
associated with the mortality rate applied to the Veteran accessions
noted above.
To calculate the survivor caseload associated with Veterans who
never filed a claim and died prior to 2010, general mortality rates
were applied to the estimated total Vietnam Veteran population (2.6
million). We estimate that almost 500,000 Vietnam Veterans were
deceased by 2010. Prevalence rates for each condition were applied to
the total Veteran deaths to estimate the number of deaths due to each
condition. With the marriage rate and survivor mortality applied, we
anticipate 20,961 eligible spouses at the end of 2010. We assume that
half of this population will apply in 2010 and the remaining in 2011.
Obligations were calculated by applying average survivor compensation
payments to the caseload each year.
The second group of survivors associated with Veteran accessions
was calculated by applying mortality rates for each of the presumptive
conditions to the estimated eligible Veteran population (28,934). In
2010, 57 Veteran deaths are anticipated as a result of one of the new
presumptive conditions. With the marriage rate applied and aging the
spouse population (and assuming spouses were the same age as Veterans),
we calculated 42 spouses at the end of 2010. Average survivor
compensation payments were applied to the spouse caseload to determine
total obligations.
Veteran and Survivor Accessions Cumulative Caseload and Total
Obligations
------------------------------------------------------------------------
Veteran Survivor Total
FY caseload caseload obligations
------------------------------------------------------------------------
2010................................. 28,934 10,416 $675,214
2011................................. 32,270 20,265 882,974
2012................................. 35,541 20,693 955,525
2013................................. 38,744 20,487 1,028,467
2014................................. 41,874 20,283 1,103,429
2015................................. 44,928 20,081 1,179,725
2016................................. 47,900 19,881 1,257,259
2017................................. 50,787 19,682 1,335,922
2018................................. 53,583 19,485 1,415,601
2019................................. 56,285 19,290 1,496,178
----------------------------------
Total............................ ......... ......... 11,330,294
------------------------------------------------------------------------
Estimated Claims From Veterans Not Eligible
Based on program history, we anticipate that we will also receive
claims from Veterans who will not be eligible for presumptive service
connection for the three new conditions.
These claims will be received from two primary populations:
Veterans with a presumptive disease who did not serve in
the Republic of Vietnam.
Claims from Vietnam Veterans with hypertension who claim
``heart disease.''
We applied the prevalence rate of IHD, Parkinson's disease and
hairy cell/B cell leukemia to the estimated population of Veterans who
served in Southeast Asia during the Vietnam Era (45,304, 32, and 6
respectively), and assumed that 10 percent of that population will
apply for presumptive service connection.
Review of data obtained from PA&I shows that 23 percent of Vietnam
Veterans who have been denied entitlement to service connection for
hypertension also have nonservice-connected heart disease. We applied
the prevalence rate of hypertension to the living Vietnam Veteran
population, and then subtracted 23 percent who are assumed to also have
IHD. We assumed that 10 percent of the remaining population would apply
for presumptive service connection to arrive at an estimated caseload
of 111,256.
We then assumed that 25 percent of the ineligible population would
apply in 2010, 25 percent would apply in 2011, and the remaining
population would apply over the next 8 years. For purposes of claims
processing, anticipated claims are as follows. The chart below reflects
workload, which is not directly comparable to the preceding caseload
charts.
Total Claims
----------------------------------------------------------------------------------------------------------------
Retroactive Reopened Claims not
FY claims claims Accessions eligible Total claims
----------------------------------------------------------------------------------------------------------------
2010............................ 86,069 32,606 39,350 27,814 185,839
2011............................ .............. 1,069 13,806 27,814 42,689
[[Page 14398]]
2012............................ .............. 1,051 3,386 6,954 11,391
2013............................ .............. 1,032 3,329 6,954 11,314
2014............................ .............. 1,011 3,267 6,954 11,232
2015............................ .............. 989 3,201 6,954 11,143
2016............................ .............. 989 3,129 6,953 11,071
2017............................ .............. 989 3,053 6,953 10,995
2018............................ .............. 989 2,971 6,953 10,913
2019............................ .............. 989 2,885 6,953 10,827
----------------------------------------------------------------------------------------------------------------
VBA Administrative Costs
Administrative costs, including minor construction and information
technology support are estimated to be $4.6 million during FY2010, $841
million for five years and $940 million over ten years.
C&P Service, along with the Office of Field Operations, estimated
the FTE that would be required to process the anticipated claims
resulting from the new presumptive conditions using the following
assumptions:.
1. 185,839 additional claims in addition to the projected 1,146,508
receipts during FY2010. This includes:
86,069 retroactive readjudications under Nehmer.
89,354 new and reopened claims from veterans.
10,416 new claims from survivors.
2. The average number of days to complete all claims in FY2010 will
be 165.
3. Priority will be given to those Agent Orange claims that fall in
the Nehmer class action.
In FY2010, we will leverage the existing C&P workforce to process
as many of these new claims as possible, once the regulation is
approved, but especially the Nehmer cases. However, to fully
accommodate this additional claims volume with as little negative
impact as possible on the processing of other claims, we plan to add
1,772 claims processors to be brought on in the FY2011 budget and
timeframe. This approximate level of effort will be sustained through
2012 and into 2013 in order to process these claims without
significantly degrading the processing of the non-presumptive workload.
Net administrative costs for payroll, training, additional
office space, supplies and equipment are estimated to be $4.6 million
in FY2010, $165 million in FY2011, $798 million over five years, and
$895 million over 10 years. Additional support costs for minor
construction are expected to be $12.8 million over the five and ten
year period. Information Technology (computers and support) are assumed
to require $30.2 million over five years and $32.8 million over ten
years.
Veterans Health Administration (VHA) Costs
We estimate VHA's total cost to be $236 million during the first
year (FY2010), $976 million for five years, and $2.5 billion over ten
years.
FY2010 and FY2011 Summary:
FY2010 new enrollee patients are expected to number 8,680.
FY2011 additional new enrollees are expected to number
1,018.
FY2010 costs for C&P examinations are expected to be
$114M.
FY2011 costs for C&P examinations are expected to be $23M.
FY2010 health care costs (inclusive of travel) are
expected to be $236M (using cost per patient of 13,500).
FY2011 health care costs (inclusive of travel) are
expected to be $165M (using cost per patient of 14,100).
Combined costs are as follows:
[cir] FY2010: $236M.
[cir] FY2011: $165M.
Assumptions
30% of Veterans newly determined to be service-connected
will enroll and will use VA health care.
Newly enrolled Veterans will be Priority Group 1 Veterans.
The cost per patient is arrived at using the average cost
per Priority Group 1 patient aged between 45-64.
Every VBA case will require a new exam.
It is assumed that 100% of newly enrolled Veterans will
request mileage reimbursement. The average amount of mileage
reimbursement claims per Veteran is $511 (this amount reflects to the
FY2009 actual average amount).
Distribution of Disability Claims
VBA has established estimates for claims workload for Veterans.
Figure 1 provides breakdown of disability claims.
Overall, VBA anticipates 69,957 claims. Of these, 17,039 will be
for Veterans whose previous claims for disability compensation were
denied. Additionally, VBA anticipates reopened claim volume of 32,606
claims in FY2010 with subsequent decreases to 1,069 per year in FY2011.
VBA anticipates 28,934 accessions in FY2010. These are new disability
compensation awards--for Veterans who did not previously have an award
for service connected disability compensation. Additionally, in FY2010
VBA anticipates disability claim volume associated with the presumptive
SC determination to be 159,311 and to exceed 270,000 through FY2019.
Figure 1
----------------------------------------------------------------------------------------------------------------
Retroactive
claims
Retroactive representing Reopened Total
FY claims new SC claims Accessions disability
disability claim volume
award
----------------------------------------------------------------------------------------------------------------
2010............................ 69,957 17,039 32,606 28,934 159,311
2011............................ .............. .............. 1,069 3,393 31,207
2012............................ .............. .............. 1,051 3,335 10,289
2013............................ .............. .............. 1,032 3,273 10,227
[[Page 14399]]
2014............................ .............. .............. 1,011 3,207 10,161
-------------------------------------------------------------------------------
Subtotals................... .............. .............. 36,769 42,142 221,195
-------------------------------------------------------------------------------
2015............................ .............. .............. 989 3,137 10,091
2016............................ .............. .............. 989 3,062 10,016
2017............................ .............. .............. 989 2,983 9,937
2018............................ .............. .............. 989 2,898 9,852
2019............................ .............. .............. 989 2,809 9,763
-------------------------------------------------------------------------------
Totals...................... 69,957 .............. 41,714 57,031 270,854
----------------------------------------------------------------------------------------------------------------
New Enrollments and Changed Enrollments
The disability compensation workload, the resulting increases in
service-connected patients, and the increased combined service
connected percents will both add new patients to VA's health care
system and will change the priority levels of Veterans currently
enrolled in VA's health care system.
For purposes of estimation, it is assumed that 30% of Veterans
``Accessions'' will enroll in the system each year. For FY2010, this
means that 8,680 of the 28,934 Veteran ``Accessions''. Figure 2
provides the estimate of new enrollments per year for the ten year
period. In all, it is estimated that 17,109 new Veterans will enroll in
VA's health care system.
Figure 2
------------------------------------------------------------------------
New enrollees New enrollees
FY per year cumulative
------------------------------------------------------------------------
2010.................................... 8,680 8,680
2011.................................... 1,018 9,698
2012.................................... 1,001 10,699
2013.................................... 982 11,681
2014.................................... 962 12,643
-------------------------------
Subtotals............................. 12,643 ..............
-------------------------------
2015.................................... 941 13,584
2016.................................... 919 14,502
2017.................................... 895 15,397
2018.................................... 869 16,267
2019.................................... 843 17,109
-------------------------------
Totals................................ 17,109 17,109
------------------------------------------------------------------------
It is assumed that Veterans enrolling will be Priority Group 1
Veterans and that they will use VA health care services.
For purposes of estimation, it is assumed that 40% of the Veterans
whose claims are reopened will have been enrolled in VA's health care
system and that their Priority Group will move from a copay required
status to a copay exempt status. Additionally, it is assumed that their
third party collections will be lost. It is assumed that 10% of the
accessions will result in changes to Veterans who are currently
enrolled. These Veterans would be enrolled in a copay required status
and would move to copay exempt status. In FY2010 it is estimated that
43,919 Veterans would have their enrollment status changed, and FY 2011
it is estimated that an additional 767 Veterans would have their
enrollment status changed. Figure 3 provides these estimated changes in
enrollment status per year and cumulatively.
Figure 3
------------------------------------------------------------------------
Upgraded Upgraded
FY enrollees per enrollees
year cumulative
------------------------------------------------------------------------
2010.................................... 43,919 43,919
2011.................................... 767 44,686
2012.................................... 754 45,439
2013.................................... 740 46,180
2014.................................... 725 46,905
-------------------------------
Subtotals............................. 46,905 46,905
-------------------------------
2015.................................... 709 47,614
2016.................................... 702 48,316
2017.................................... 694 49,010
2018.................................... 685 49,695
2019.................................... 677 50,372
-------------------------------
Totals................................ 50,372 50,372
------------------------------------------------------------------------
Disability Exams Associated Costs
It is assumed that each VBA case will result in disability
examinations for the Veteran. In all, it is estimated that 270,854
disability examinations will need to be performed. An escalation factor
of 4% is applied to cost of disability examinations.
Figure 4
----------------------------------------------------------------------------------------------------------------
Total disability Cost per Annual cost per
FY claim volume disability exam * disability exams
----------------------------------------------------------------------------------------------------------------
2010................................................... 159,311 $719 $114,544,609
2011................................................... 31,207 748 23,335,346
2012................................................... 10,289 778 8,001,451
2013................................................... 10,227 809 8,271,365
2014................................................... 10,161 841 8,546,705
--------------------------------------------------------
Subtotals.......................................... 221,195 ................. 162,699,475
--------------------------------------------------------
2015................................................... 10,091 875 8,827,339
2016................................................... 10,016 910 9,112,200
2017................................................... 9,937 946 9,401,942
2018................................................... 9,852 984 9,694,379
2019................................................... 9,763 1,023 9,991,075
--------------------------------------------------------
[[Page 14400]]
Totals............................................. 270,854 ................. 209,726,410
----------------------------------------------------------------------------------------------------------------
* Source: Allocation Resource Center.
Health Care and Total Costs
Figure 5 provides extended health care costs per year and includes
costs for C&P disability examinations and travel associated